<!DOCTYPE html><html><head><meta charset="UTF-8"><style>table, th, td{border: 1px solid black;}</style><body>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-10db92f9-2300-4a80-836b-673e1ae91610-clinicalPharmacology-0.txt'/><table id="table7" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7:          Percent Increase of Rivaroxaban PK and PD Parameters from Normal in Subjects with Renal Insufficiency from a Dedicated Renal Impairment Study</caption>
<col align="center" valign="top" width="33%"></col>
<col align="center" valign="top" width="7%"></col>
<col align="center" valign="top" width="20%"></col>
<col align="center" valign="top" width="20%"></col>
<col align="center" valign="top" width="20%"></col>
<thead>
<tr>
<th colspan="2"></th>
<th colspan="3" stylecode="Botrule">CrCl (mL/min)</th>
</tr>
<tr>
<th colspan="2">Parameter</th>
<th>50 to 79<br/>N = 8</th>
<th>30 to 49<br/>N = 8</th>
<th>15 to 29<br/>N = 8</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="5" valign="top">PT = Prothrombin time; FXa = Coagulation factor Xa; AUC = Area under the concentration or effect curve; C<sub>max </sub>= maximum concentration; E<sub>max </sub>= maximum effect; and CrCl = creatinine clearance</td>
</tr>
</tfoot>
<tbody>
<tr>
<td>
<content stylecode="bold">Exposure</content>
</td>
<td>
<content stylecode="bold">AUC</content>
</td>
<td>44</td>
<td>52</td>
<td>64</td>
</tr>
<tr>
<td>
<content stylecode="bold">(% increase relative to normal)</content>
</td>
<td>
<content stylecode="bold">C<sub>max</sub>
</content>
</td>
<td>28</td>
<td>12</td>
<td>26</td>
</tr>
<tr>
<td>
<content stylecode="bold">FXa Inhibition</content>
</td>
<td>
<content stylecode="bold">AUC</content>
</td>
<td>50</td>
<td>86</td>
<td>100</td>
</tr>
<tr>
<td>
<content stylecode="bold">(% increase relative to normal)</content>
</td>
<td>
<content stylecode="bold">E<sub>max</sub>
</content>
</td>
<td>9</td>
<td>10</td>
<td>12</td>
</tr>
<tr>
<td>
<content stylecode="bold">PT Prolongation</content>
</td>
<td>
<content stylecode="bold">AUC</content>
</td>
<td>33</td>
<td>116</td>
<td>144</td>
</tr>
<tr stylecode="Botrule">
<td>
<content stylecode="bold">(% increase relative to normal)</content>
</td>
<td>
<content stylecode="bold">E<sub>max</sub>
</content>
</td>
<td>4</td>
<td>17</td>
<td>20</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-10db92f9-2300-4a80-836b-673e1ae91610-clinicalPharmacology-1.txt'/><table id="table8" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8:          Percent Increase of Rivaroxaban PK and PD Parameters from Normal in Subjects with Hepatic Insufficiency from a Dedicated Hepatic Impairment Study</caption>
<col align="center" valign="top" width="33%"></col>
<col align="center" valign="top" width="7%"></col>
<col align="center" valign="top" width="30%"></col>
<col align="center" valign="top" width="30%"></col>
<thead>
<tr>
<th colspan="2"></th>
<th colspan="2" stylecode="Botrule">Hepatic Impairment Class<br/>(Child-Pugh Class)</th>
</tr>
<tr>
<th colspan="2">Parameter</th>
<th>Mild<br/>(Child-Pugh A)<br/>N = 8</th>
<th>Moderate<br/>(Child-Pugh B)<br/>N = 8</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="4" valign="top">PT = Prothrombin time; FXa = Coagulation factor Xa; AUC = Area under the concentration or effect curve; C<sub>max </sub>= maximum concentration; E<sub>max </sub>= maximum effect</td>
</tr>
</tfoot>
<tbody>
<tr>
<td>
<content stylecode="bold">Exposure</content>
</td>
<td>
<content stylecode="bold">AUC</content>
</td>
<td>15</td>
<td>127</td>
</tr>
<tr>
<td>
<content stylecode="bold">(% increase relative to normal)</content>
</td>
<td>
<content stylecode="bold">C<sub>max</sub>
</content>
</td>
<td>0</td>
<td>27</td>
</tr>
<tr>
<td>
<content stylecode="bold">FXa Inhibition</content>
</td>
<td>
<content stylecode="bold">AUC</content>
</td>
<td>8</td>
<td>159</td>
</tr>
<tr>
<td>
<content stylecode="bold">(% increase relative to normal)</content>
</td>
<td>
<content stylecode="bold">E<sub>max</sub>
</content>
</td>
<td>0</td>
<td>24</td>
</tr>
<tr>
<td>
<content stylecode="bold">PT Prolongation</content>
</td>
<td>
<content stylecode="bold">AUC</content>
</td>
<td>6</td>
<td>114</td>
</tr>
<tr stylecode="Botrule">
<td>
<content stylecode="bold">(% increase relative to normal)</content>
</td>
<td>
<content stylecode="bold">E<sub>max</sub>
</content>
</td>
<td>2</td>
<td>41</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-1fd0ba23-962e-427f-8b9d-2cf8f64d0f95-clinicalPharmacology-0.txt'/><table id="_RefID0E2TBG" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4. Effect of Coadministered Drugs on Rosuvastatin Systemic Exposure</caption>
<col width="40%"></col>
<col width="17%"></col>
<col width="17%"></col>
<col width="18%"></col>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Coadministered drug and dosing regimen</content>
</paragraph>
</td>
<td align="center" colspan="3" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Rosuvastatin</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule "></td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Dose (mg)</content>
<footnote id="_Ref344365669">Single dose unless otherwise noted.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Change in AUC</content>
<footnote id="_Ref344365840">Mean ratio (with/without coadministered drug and no change = 1fold) or % change (with/without coadministered drug and no change = 0%); symbols of ↑ and ↓ indicate the exposure increase and decrease, respectively.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Change in C<sub>max</sub>
</content>
<footnoteref idref="_Ref344365840"></footnoteref>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Cyclosporine – stable dose required (75 mg – 200 mg BID)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>10 mg QD for 10 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 7.1-fold<footnote id="_Ref392744696">Clinically significant [see<content stylecode="italics">
<linkhtml href="#tylerr1187016457870">Dosage and Administration (2)</linkhtml>
</content> and<content stylecode="italics">
<linkhtml href="#tylerr1187016578885">Warnings and Precautions (5)</linkhtml>
</content>]</footnote>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<list listtype="unordered">
<item>
<caption> </caption>↑ 11-fold<footnoteref idref="_Ref392744696"></footnoteref>
</item>
</list>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Atazanavir/ritonavir combination 300 mg/100 mg QD for 8 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>10 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 3.1-fold<footnoteref idref="_Ref392744696"></footnoteref>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<list listtype="unordered">
<item>
<caption> </caption>↑ 7-fold<footnoteref idref="_Ref392744696"></footnoteref>
</item>
</list>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Lopinavir/ritonavir combination 400 mg/100 mg BID for 17 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>20 mg QD for 7 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 2.1-fold<footnoteref idref="_Ref392744696"></footnoteref>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<list listtype="unordered">
<item>
<caption> </caption>↑ 5-fold<footnoteref idref="_Ref392744696"></footnoteref>
</item>
</list>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Gemfibrozil 600 mg BID for 7 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>80 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 1.9-fold<footnoteref idref="_Ref392744696"></footnoteref>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<list listtype="unordered">
<item>
<caption> </caption>↑ 2.2-fold<footnoteref idref="_Ref392744696"></footnoteref>
</item>
</list>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Eltrombopag 75 mg QD, 5 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>10 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 1.6-fold</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<list listtype="unordered">
<item>
<caption> </caption>↑ 2-fold</item>
</list>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Darunavir 600 mg/ritonavir 100 mg BID, 7 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>10 mg QD for 7 days<br/>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 1.5-fold</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 2.4-fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Tipranavir/ritonavir combination 500 mg/200mg BID for 11 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>10 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 26%</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 2.2-fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Dronedarone 400 mg BID</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>10 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 1.4-fold</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Itraconazole 200 mg QD, 5 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>10 mg or 80 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 39%</paragraph>
<paragraph>↑ 28%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<list listtype="unordered">
<item>
<caption> </caption>↑ 36%</item>
<item>
<caption> </caption>↑ 15%</item>
</list>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Ezetimibe 10 mg QD, 14 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>10 mg QD for 14 days</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<list listtype="unordered">
<item>
<caption> </caption>↑ 1.2-fold</item>
</list>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Fosamprenavir/ritonavir 700 mg/100 mg BID for 7 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>10 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 8%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<list listtype="unordered">
<item>
<caption> </caption>↑ 45%</item>
</list>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Fenofibrate 67 mg TID for 7 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>10 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↑ 21%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Rifampicin 450 mg QD, 7 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>20 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle"></td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Aluminum &amp; magnesium hydroxide combination antacid</paragraph>
<paragraph>Administered simultaneously<br/>Administered 2 hours apart</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>40 mg<br/>40 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↓ 54%<footnoteref idref="_Ref392744696"></footnoteref>
<br/>↓ 22%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<list listtype="unordered">
<item>
<caption> </caption>↓ 50%<footnoteref idref="_Ref392744696"></footnoteref>
<br/>↓ 16%</item>
</list>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Ketoconazole 200 mg BID for 7 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>80 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↑ 2%</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↓ 5%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Fluconazole 200 mg QD for 11 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>80 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↑ 14%</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↑ 9%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>Erythromycin 500 mg QID for 7 days</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule ">
<paragraph>80 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule ">
<paragraph>↓ 20%</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule ">
<paragraph>↓ 31%</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-1fd0ba23-962e-427f-8b9d-2cf8f64d0f95-clinicalPharmacology-1.txt'/><table id="_RefID0E2CAI" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 5. Effect of Rosuvastatin Coadministration on Systemic Exposure To Other Drugs</caption>
<col width="22%"></col>
<col width="50%"></col>
<col width="14%"></col>
<col width="14%"></col>
<thead>
<tr>
<th align="left" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<content stylecode="bold">Rosuvastatin Dosage Regimen</content>
</th>
<th align="left" colspan="3" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<content stylecode="bold">Coadministered Drug</content>
</th>
</tr>
<tr>
<th align="left" stylecode="Rrule Lrule Botrule " valign="top"></th>
<th align="left" stylecode="Rrule Lrule Botrule " valign="top">
<content stylecode="bold">Name and Dose</content>
</th>
<th align="left" stylecode="Rrule Lrule Botrule " valign="top">
<content stylecode="bold">Change in AUC</content>
</th>
<th align="left" stylecode="Rrule Lrule Botrule " valign="top">
<content stylecode="bold">Change in C<sub>max</sub>
</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>40 mg QD for 10 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>Warfarin<footnote id="_RefFN1194543202-1">Clinically significant pharmacodynamic effects [see<content stylecode="italics">
<linkhtml href="#williamsonbk1194553111202">Warnings and Precautions (5.3)</linkhtml>
</content>]</footnote>
</paragraph>
<paragraph>25 mg single dose </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>R- Warfarin ↑ 4%</paragraph>
<paragraph>S-Warfarin ↑6%</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>R-Warfarin ↓ 1%</paragraph>
<paragraph>S-Warfarin 0%</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>40 mg QD for 12 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>Digoxin </paragraph>
<paragraph>0.5 mg single dose</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↑ 4%</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↑ 4%</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>40 mg QD for 28 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>Oral Contraceptive</paragraph>
<paragraph>(ethinyl estradiol 0.035 mg &amp; norgestrel 0.180, 0.215 and 0.250 mg) QD for 21 Days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>EE ↑ 26%</paragraph>
<paragraph>NG ↑ 34%</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>EE ↑ 25%</paragraph>
<paragraph>NG ↑ 23%</paragraph>
</td>
</tr>
<tr>
<td colspan="4" stylecode="Botrule ">
<paragraph>EE = ethinyl estradiol, NG = norgestrel</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-326e8ab0-6886-4749-9544-885b37070051-clinicalPharmacology-0.txt'/><table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<thead>
<tr>
<th align="center" colspan="5" stylecode="Lrule Rrule Toprule">Outcome Classification (%) on CGI-Global Improvement Item for Completers in Study 1 </th>
</tr>
<tr>
<th align="center" stylecode="Lrule Rrule Toprule">Outcome <br/>Classification </th>
<th align="center" stylecode="Lrule Rrule Toprule">Placebo<br/>(n = 74) </th>
<th align="center" stylecode="Lrule Rrule Toprule">Paroxetine<br/>20 mg<br/>(n = 75) </th>
<th align="center" stylecode="Lrule Rrule Toprule">Paroxetine<br/>40 mg<br/>(n = 66) </th>
<th align="center" stylecode="Lrule Rrule Toprule">Paroxetine<br/>60 mg<br/>(n = 66) </th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> Worse <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">14% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">7% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">7% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">3% <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> No Change <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">44% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">35% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">22% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">19% <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> Minimally Improved <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">24% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">33% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">29% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">34% <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> Much Improved <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">11% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">18% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">22% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">24% <br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top"> Very Much Improved <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">7% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">7% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">20% <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">20% <br/>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-44dcbf97-99ec-427c-ba50-207e0069d6d2-clinicalPharmacology-0.txt'/><table id="t2" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2.  Effect of Co-Administered Drugs on Pitavastatin Systemic Exposure
</caption>
<col align="left" width="24.825%"></col>
<col align="left" width="43.500%"></col>
<col align="left" width="14.375%"></col>
<col align="left" width="17.300%"></col>
<tfoot>
<tr>
<td align="left" colspan="4" valign="top">
<paragraph stylecode="footnote">
<content stylecode="bold">
<sup>*</sup>
</content>Data presented as x-fold change represent the ratio between co-administration and pitavastatin alone (i.e., 1-fold = no change).  Data presented as % change represent % difference relative to pitavastatin alone (i.e., 0% = no change).
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="4" valign="top">
<paragraph stylecode="footnote">† Considered clinically significant <content stylecode="italics">[see Dosage and Administration (<linkhtml href="#s4">2</linkhtml>) and Drug Interactions (<linkhtml href="#s18">7</linkhtml>)]</content>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="4" valign="top">
<paragraph stylecode="footnote">BID = twice daily; QD = once daily; LA = Long Acting
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" stylecode="Toprule Botrule Lrule Rrule" valign="middle">Co-administered drug
</td>
<td align="center" stylecode="Toprule Botrule Rrule" valign="middle">Dose regimen
</td>
<td align="center" stylecode="Toprule Botrule Rrule" valign="middle">Change in<br/>AUC*
</td>
<td align="center" stylecode="Toprule Botrule Rrule" valign="middle">Change in  C<sub>max*</sub>
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Cyclosporine
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 2 mg QD for 6 days + cyclosporine 2 mg/kg on Day 6
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 4.6 fold†
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 6.6 fold †
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Erythromycin
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg single dose on Day 4 + erythromycin 500 mg 4 times daily for 6 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 2.8 fold †
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 3.6 fold †
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Rifampin
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + rifampin 600 mg QD for 5 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 29%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 2.0 fold
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Atazanavir
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + atazanavir 300 mg daily for 5 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 31%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 60%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Darunavir/Ritonavir
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4mg QD on Days 1-5 and 12-16 + darunavir/ritonavir  800mg/100 mg QD on Days 6-16
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 26%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 4%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Lopinavir/Ritonavir
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD on Days 1-5 and 20-24 + lopinavir/ritonavir 400 mg/100 mg BID on Days 9 – 24
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 20%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓4 %
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Gemfibrozil
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + gemfibrozil 600 mg BID for 7 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 45%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 31%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Fenofibrate
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + fenofibrate 160 mg QD for 7 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑18%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 11%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Ezetimibe
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 2 mg QD  + ezetimibe 10 mg for 7 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 2%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓0.2%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Enalapril
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + enalapril 20 mg daily for 5 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 6%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 7%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Digoxin
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + digoxin 0.25 mg for 7 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 4%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 9%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Diltiazem LA
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD on Days 1-5 and 11-15 and diltiazem LA 240 mg on Days 6-15
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑10%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑15%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Grapefruit Juice
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 2 mg single dose on Day 3 + grapefruit juice for 4 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 15%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 12%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Itraconazole
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg single dose on Day 4 + itraconazole 200 mg daily for 5 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 23%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 22%
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-44dcbf97-99ec-427c-ba50-207e0069d6d2-clinicalPharmacology-1.txt'/><table id="t3" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3.  Effect of Pitavastatin Co-Administration on Systemic Exposure to Other Drugs
</caption>
<col align="left" width="25.540%"></col>
<col align="left" width="24.680%"></col>
<col align="left" width="19.920%"></col>
<col align="left" width="14.920%"></col>
<col align="left" width="14.940%"></col>
<tfoot>
<tr>
<td align="left" colspan="5" valign="top">
<paragraph stylecode="footnote">*Data presented as % change represent % difference relative to the investigated drug alone
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="5" valign="top">
<paragraph stylecode="footnote">(i.e., 0% = no change).
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="5" valign="top">
<paragraph stylecode="footnote">BID = twice daily; QD = once daily; LA = Long Acting
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" stylecode="Toprule Botrule Lrule Rrule" valign="middle">Co-administered drug
</td>
<td align="center" colspan="2" stylecode="Toprule Botrule Rrule" valign="middle">Dose regimen
</td>
<td align="center" stylecode="Toprule Botrule Rrule" valign="middle">Change in<br/>AUC*
</td>
<td align="center" stylecode="Toprule Botrule Rrule" valign="middle">Change in  C<sub>max</sub>*
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Atazanavir
</td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + atazanavir 300 mg daily for 5 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 6%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 13%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Darunavir
</td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4mg QD on Days 1-5 and 12-16 + darunavir/ritonavir  800mg/100 mg QD on Days 6-16
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 3%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 6%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Lopinavir
</td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD on Days 1-5 and 20-24 + lopinavir/ritonavir 400 mg/100 mg BID on Days 9 – 24
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 9%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 7%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Ritonavir
</td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD on Days 1-5 and 20-24 + lopinavir/ritonavir 400 mg/100 mg BID on Days 9 – 24
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 11%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 11%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Ritonavir
</td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4mg QD on Days 1-5 and 12-16 + darunavir/ritonavir  800mg/100 mg QD on Days 6-16
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 8%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 2%
</td>
</tr>
<tr>
<td align="left" rowspan="2" stylecode="Botrule Lrule Rrule" valign="middle">Enalapril
</td>
<td align="left" rowspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + enalapril 20 mg<br/>daily for 5 days
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">Enalapril
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 12%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 12%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Rrule" valign="middle">Enalaprilat
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 1%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 1%
</td>
</tr>
<tr>
<td align="left" rowspan="2" stylecode="Botrule Lrule Rrule" valign="middle">Warfarin
</td>
<td align="left" rowspan="2" stylecode="Botrule Rrule" valign="middle">Individualized maintenance dose of warfarin (2 - 7 mg) for 8 days + pitavastatin 4 mg QD for 9 days
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">R-warfarin
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 7%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 3%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Rrule" valign="middle">S-warfarin
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 6%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 3%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Ezetimibe
</td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 2 mg QD  + ezetimibe 10 mg for 7 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 9%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↑ 2%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Digoxin
</td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + digoxin 0.25 mg for 7 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 3%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 4%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Diltiazem LA
</td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD on Days 1-5 and 11-15 and diltiazem LA 240 mg on Days 6-15
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 2%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 7%
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="middle">Rifampin
</td>
<td align="left" colspan="2" stylecode="Botrule Rrule" valign="middle">Pitavastatin 4 mg QD + rifampin 600 mg QD for 5 days
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 15%
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">↓ 18%
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-49c4105b-e518-481c-a248-6684135f5bc1-drugInteractions-0.txt'/><table id="_RefID0E1OBK" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 18  Summary of Effect of Coadministered Drugs on Exposure to Active Moiety (Risperidone + 9-Hydroxy-Risperidone) in Healthy Subjects or Patients with Schizophrenia</caption>
<col width="27%"></col>
<col width="15%"></col>
<col width="12%"></col>
<col width="9%"></col>
<col width="9%"></col>
<col width="28%"></col>
<tbody>
<tr>
<td stylecode="Rrule Lrule Toprule ">
<paragraph> Coadministered Drug<br/>
</paragraph>
</td>
<td colspan="2" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph> Dosing Schedule<br/>
</paragraph>
</td>
<td colspan="2" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph> Effect on Active<br/>Moiety (Risperidone + 9-<br/>Hydroxy- Risperidone (Ratio*)<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph> Risperidone Dose<br/>Recommendation<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Coadministered Drug<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Risperidone<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> AUC<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Cmax<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Enzyme (CYP2D6)<br/>Inhibitors<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Fluoxetine<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 20 mg/day <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 2 or 3 mg twice<br/>daily<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.4 <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.5<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Re-evaluate dosing. Do not exceed 8 mg/day<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> Paroxetine<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 10 mg/day <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 4 mg/day<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.3<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <content stylecode="bold">-</content>
<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule ">
<paragraph> Re-evaluate dosing. <br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 20 mg/day <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 4 mg/day<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.6<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <content stylecode="bold">-</content>
<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule ">
<paragraph> Do not exceed 8 mg/day<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 40 mg/day <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 4 mg/day<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.8<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <content stylecode="bold">-</content>
<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Enzyme (CYP3A/ PgP inducers) Inducers<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Carbamazepine <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 573 ± 168 mg/day<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 3 mg twice daily<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 0.51 <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 0.55<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Titrate dose upwards.<br/>Do not exceed twice the patient’s usual dose<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Enzyme (CYP3A)<br/>Inhibitors<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Ranitidine <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 150 mg twice daily<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1 mg single dose<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.2 <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.4<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Dose adjustment not<br/>needed<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Cimetidine <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 400 mg twice daily<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1 mg single dose<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.1 <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.3<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Dose adjustment not<br/>needed<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Erythromycin <br/>
<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 500 mg four times<br/>daily<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1 mg single dose<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 1.1 <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 0.94<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Dose adjustment not<br/>needed<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> Other Drugs<br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> <br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph> Amitriptyline <br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph> 50 mg twice daily<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph> 3 mg twice daily<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph> 1.2 <br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph> 1.1<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph> Dose adjustment not<br/>needed<br/>
</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-4c401522-0108-49cb-8a41-fb5ad4dd0fb1-clinicalPharmacology-0.txt'/><table id="table16" width="90%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table  16: Comparison of C<sub>max</sub> and T<sub>max</sub> Values for Venlafaxine  and ODV Following Oral Administration of Venlafaxine hydrochloride Extended-Release  and Venlafaxine hydrochloride Immediate-Release)</caption>
<col align="left" valign="top" width="40%"></col>
<col align="left" valign="top" width="15%"></col>
<col align="left" valign="top" width="15%"></col>
<col align="left" valign="top" width="15%"></col>
<col align="left" valign="top" width="15%"></col>
<thead>
<tr>
<th></th>
<th colspan="2">Venlafaxine</th>
<th colspan="2">ODV</th>
</tr>
<tr>
<th></th>
<th>C<sub>max</sub>
<br/>(ng/mL)</th>
<th>T<sub>max</sub>
<br/>(h)</th>
<th>C<sub>max</sub>
<br/>(ng/mL)</th>
<th>T<sub>max</sub>
<br/>(h)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Venlafaxine hydrochloride Extended-Release (150 mg once daily)</td>
<td>150</td>
<td>5.5</td>
<td>260</td>
<td>9</td>
</tr>
<tr>
<td>Venlafaxine hydrochloride Immediate-Release (75 mg twice daily)</td>
<td>225</td>
<td>2</td>
<td>290</td>
<td>3</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-4c401522-0108-49cb-8a41-fb5ad4dd0fb1-drugInteractions-0.txt'/><table id="fig1" stylecode="Noautorules" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Figure 1: Effect of interacting drugs on the pharmacokinetics of venlafaxine and active metabolite O-desmethylvenlafaxine (ODV).</caption>
<col align="left" valign="top" width="100%"></col>
<tbody>
<tr>
<td>
<paragraph>
<rendermultimedia referencedobject="MM1"></rendermultimedia>
</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-4c401522-0108-49cb-8a41-fb5ad4dd0fb1-drugInteractions-1.txt'/><table id="fig2" stylecode="Noautorules" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Figure 2: Effect of venlafaxine on the pharmacokinetics interacting drugs and their active metabolites.</caption>
<col align="left" valign="top" width="100%"></col>
<tbody>
<tr>
<td>
<paragraph>
<rendermultimedia referencedobject="MM2"></rendermultimedia>
</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-4e1e5249-1cb7-4cc2-ad5a-cdeeee2f494f-clinicalPharmacology-0.txt'/><table xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 17: The Effect of Other Drugs on the Pharmacokinetics of Quetiapine</caption>
<col width="29%"></col>
<col width="29%"></col>
<col width="29%"></col>
<col width="29%"></col>
<tbody>
<tr>
<td align="center" rowspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Coadministered</content>
</paragraph>
<paragraph>
<content stylecode="bold">drug</content>
</paragraph>
</td>
<td align="center" colspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Dose schedules</content>
</paragraph>
</td>
<td align="center" rowspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Effect on</content>
</paragraph>
<paragraph>
<content stylecode="bold">quetiapine</content>
</paragraph>
<paragraph>
<content stylecode="bold">pharmacokinetics</content>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>
<content stylecode="bold">Coadministered </content>
</paragraph>
<paragraph>
<content stylecode="bold">drug</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule" valign="middle">
<paragraph>
<content stylecode="bold">Quetiapine</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Phenytoin</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>100 mg three times daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>250 mg three times daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>5 fold Increase in oral clearance</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Divalproex</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule" valign="top">
<paragraph>500 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule" valign="top">
<paragraph>150 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule" valign="top">
<paragraph>17% increase mean max plasma concentration at steady state.</paragraph>
<paragraph>No effect on absorption or mean oral clearance</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Thioridazine</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>200 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>300 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>65% increase in oral clearance</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Cimetidine</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>400 mg three times daily for 4 days</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>150 mg three times daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>20% decrease in mean oral clearance</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Ketoconazole (potent CYP 3A4 inhibitor)</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>200 mg once daily for 4 days</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>25 mg single dose</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>84% decrease in oral clearance resulting in a 6.2 fold increase in AUC of quetiapine</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Fluoxetine</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>60 mg once daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>300 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>No change in steady state PK</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Imipramine</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>75 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>300 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>No change in steady state PK</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Haloperidol</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>7.5 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>300 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>No change in steady state PK</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Risperidone</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>3 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>300 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>No change in steady state PK</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-4e1e5249-1cb7-4cc2-ad5a-cdeeee2f494f-clinicalPharmacology-1.txt'/><table xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 18: The Effect of Quetiapine on the Pharmacokinetics of Other Drugs</caption>
<col width="29%"></col>
<col width="29%"></col>
<col width="29%"></col>
<col width="29%"></col>
<tbody>
<tr>
<td align="center" rowspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Coadministered drug</content>
</paragraph>
</td>
<td align="center" colspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Dose schedules</content>
</paragraph>
</td>
<td align="center" rowspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Effect on other drugs pharmacokinetics</content>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Coadministered drug</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Quetiapine</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Lorazepam</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>2 mg, single dose</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>250 mg three times daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Oral clearance of lorazepam reduced by 20%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Divalproex</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>500 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>150 mg twice daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>C<sub>max </sub>and AUC of free valproic acid at steady-state was decreased by 10 to 12%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Lithium</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Up to 2400 mg/day given in twice daily doses</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>250 mg three times daily</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>No effect on steady-state pharmacokinetics of lithium</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Antipyrine</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>1 g, single dose</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>250 mg three times daily</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>No effect on clearance of antipyrine or urinary recovery of its metabolites</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-51ff7db5-aaf9-4c3c-86e6-958ebf16b60f-clinicalPharmacology-0.txt'/><table id="_Refinv-b7129e82-0508-40f2-96d5-fac23644" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>AUC Multiples and T<sub>1/2</sub> for Three Metabolites of Nefazodone (100 mg BID)</caption>
<col width="33%"></col>
<col width="35%"></col>
<col width="33%"></col>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Metabolite</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule ">
<paragraph>
<content stylecode="bold">AUC Multiple</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule ">
<paragraph>
<content stylecode="bold">T<sub>1/2</sub>
</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>HO-NEF</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>0.4</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>1.5 to 4 h</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>mCPP</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>0.07</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>4 to 8 h</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="middle">
<paragraph>Triazole-dione</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>4.0</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>18 h</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-520428f1-2cd5-447f-8782-c8505ce65b72-clinicalPharmacology-0.txt'/><table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE I: The Effect of Other Drugs on Lovastatin Exposure When Both Were Co-administered</caption>
<col align="left" valign="middle" width="18%"></col>
<col align="center" valign="middle" width="15%"></col>
<col align="center" valign="middle" width="20%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="13%"></col>
<col align="center" valign="middle" width="18%"></col>
<tbody>
<tr>
<td rowspan="2" stylecode="Lrule Rrule Botrule"></td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Number of Subjects</content>
</td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Dosing of Coadministered Drug or Grapefruit Juice</content>
</td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Dosing of Lovastatin</content>
</td>
<td colspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">AUC Ratio<footnote id="ft1.1">Results based on a chemical assay.</footnote>
<br/>(with / without coadministered drug)<br/>No Effect = 1.00</content>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Botrule">
<content stylecode="bold">Lovastatin</content>
</td>
<td stylecode="Rrule Botrule">
<content stylecode="bold">Lovastatin acid</content>
<footnote>Lovastatin acid refers to the β-hydroxyacid of lovastatin.</footnote>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Gemfibrozil</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">600 mg BID for 3 days</td>
<td stylecode="Rrule">40 mg</td>
<td stylecode="Rrule">0.96</td>
<td stylecode="Rrule">2.80</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Itraconazole<footnote>The mean total AUC of lovastatin without itraconazole phase could not be determined accurately. Results could be representative of strong CYP3A4 inhibitors such as ketoconazole, posaconazole, clarithromycin, telithromycin, HIV protease inhibitors, and nefazodone.</footnote>
</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">200 mg QD for 4 days</td>
<td stylecode="Rrule">40 mg on Day 4</td>
<td stylecode="Rrule">&gt; 36<footnote id="ft1.2">Estimated minimum change. </footnote>
</td>
<td stylecode="Rrule">22</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule"></td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">100 mg QD for 4 days</td>
<td stylecode="Rrule">40 mg on Day 4</td>
<td stylecode="Rrule">&gt; 14.8<footnoteref idref="ft1.2"></footnoteref>
</td>
<td stylecode="Rrule">15.4</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Grapefruit Juice<footnote id="ft1.3">The effect of amounts of grapefruit juice between those used in these two studies on lovastatin pharmacokinetics has not been studied.</footnote>
<br/>(high dose)</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">200 mL of double-strength TID<footnote>Double-strength: one can of frozen concentrate diluted with one can of water. Grapefruit juice was administered TID for 2 days, and 200 mL together with single dose lovastatin and 30 and 90 minutes following single dose lovastatin on Day 3.</footnote>
</td>
<td stylecode="Rrule">80 mg single dose</td>
<td stylecode="Rrule">15.3</td>
<td stylecode="Rrule">5.0</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Grapefruit Juice<footnoteref idref="ft1.3"></footnoteref>
<br/>(low dose)</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">8 oz (about 250 mL) of single-strength<footnote>Single-strength: one can of frozen concentrate diluted with 3 cans of water. Grapefruit juice was administered with breakfast for 3 days, and lovastatin was administered in the evening on Day 3.</footnote> for 4 days </td>
<td stylecode="Rrule">40 mg single dose</td>
<td stylecode="Rrule">1.94</td>
<td stylecode="Rrule">1.57</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Cyclosporine</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">Not described<footnote>Cyclosporine-treated patients with psoriasis or post kidney or heart transplant patients with stable graft function, transplanted at least 9 months prior to study.</footnote>
</td>
<td stylecode="Rrule">10 mg QD for 10 days</td>
<td stylecode="Rrule">5- to 8-fold</td>
<td stylecode="Rrule">ND<footnote>ND = Analyte not determined.</footnote>
</td>
</tr>
<tr>
<td rowspan="2" stylecode="Lrule Rrule Botrule"></td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Number of Subjects</content>
</td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Dosing of Coadministered Drug or Grapefruit Juice</content>
</td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Dosing of Lovastatin</content>
</td>
<td colspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">AUC Ratio<footnoteref idref="ft1.1"></footnoteref>
<br/>(with / without coadministered drug)<br/>No Effect = 1.00</content>
</td>
</tr>
<tr stylecode="Botrule">
<td align="center" colspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Total Lovastatin acid<footnote id="ft1.4">Lactone converted to acid by hydrolysis prior to analysis. Figure represents total unmetabolized acid and lactone.</footnote>
</content>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Diltiazem</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">120 mg BID for 14 days</td>
<td stylecode="Rrule">20 mg</td>
<td colspan="2" stylecode="Rrule">3.57<footnoteref idref="ft1.4"></footnoteref>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-520428f1-2cd5-447f-8782-c8505ce65b72-clinicalPharmacology-1.txt'/><table id="id_f7009c52-ba24-44cc-9eb7-27f8be06ac31" width="625.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_ed86d771-9996-4cd6-b9cc-0ede2a4ce3ca">TABLE II: MEVACOR vs. Placebo (Mean Percent Change from Baseline After 6 Weeks)</caption>
<col width="16.6%"></col>
<col width="10.6%"></col>
<col width="11.4%"></col>
<col width="12.3%"></col>
<col width="12.3%"></col>
<col width="13.1%"></col>
<col width="12.3%"></col>
<col width="11.4%"></col>
<thead>
<tr id="id_89f05d9f-22d7-4afe-9c03-7331a1becc32">
<td align="left" stylecode="Botrule" valign="bottom">DOSAGE</td>
<td align="center" stylecode="Botrule" valign="top">N</td>
<td align="center" stylecode="Botrule" valign="top">TOTAL-C</td>
<td align="center" stylecode="Botrule" valign="top">LDL-C</td>
<td align="center" stylecode="Botrule" valign="top">HDL-C</td>
<td align="center" stylecode="Botrule" valign="top">LDL-C/<br/>HDL-C</td>
<td align="center" stylecode="Botrule" valign="top">TOTAL-C/ <br/>HDL-C</td>
<td align="center" stylecode="Botrule" valign="bottom">TG.</td>
</tr>
</thead>
<tbody>
<tr id="id_0dccbde5-c71c-43e2-89e5-34888c6d6287">
<td align="left" stylecode="Toprule" valign="bottom">Placebo</td>
<td align="center" stylecode="Toprule" valign="top">33</td>
<td align="center" stylecode="Toprule" valign="top">–2</td>
<td align="center" stylecode="Toprule" valign="top">–1</td>
<td align="center" stylecode="Toprule" valign="top">–1</td>
<td align="center" stylecode="Toprule" valign="top">0</td>
<td align="center" stylecode="Toprule" valign="top">+1</td>
<td align="center" valign="top">+9</td>
</tr>
<tr id="id_1cc79f5e-64d7-4f64-82d0-fbc69d92c19e">
<td align="left" colspan="8" valign="bottom">
<br/>MEVACOR</td>
</tr>
<tr id="id_221f2639-208a-48f0-bef6-58b7d8a9b773">
<td align="left" valign="bottom">10 mg q.p.m.</td>
<td align="center" valign="top">33</td>
<td align="center" valign="top">–16</td>
<td align="center" valign="top">–21</td>
<td align="center" valign="top">+5</td>
<td align="center" valign="top">–24</td>
<td align="center" valign="top">–19</td>
<td align="center" valign="top">–10</td>
</tr>
<tr id="id_b0b8af94-8c3f-45c4-bb8d-e65d3db0894a">
<td align="left" valign="bottom">20 mg q.p.m.</td>
<td align="center" valign="top">33</td>
<td align="center" valign="top">–19</td>
<td align="center" valign="top">–27</td>
<td align="center" valign="top">+6</td>
<td align="center" valign="top">–30</td>
<td align="center" valign="top">–23</td>
<td align="center" valign="top">+9</td>
</tr>
<tr id="id_df1ec968-a382-48fd-b409-af1be0da678e">
<td align="left" valign="bottom">10 mg b.i.d.</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">–19</td>
<td align="center" valign="top">–28</td>
<td align="center" valign="top">+8</td>
<td align="center" valign="top">–33</td>
<td align="center" valign="top">–25</td>
<td align="center" valign="top">–7</td>
</tr>
<tr id="id_7c741720-8c3e-4871-8a0c-cacd632e1732">
<td align="left" valign="bottom">40 mg q.p.m.</td>
<td align="center" valign="top">33</td>
<td align="center" valign="top">–22</td>
<td align="center" valign="top">–31</td>
<td align="center" valign="top">+5</td>
<td align="center" valign="top">–33</td>
<td align="center" valign="top">–25</td>
<td align="center" valign="top">–8</td>
</tr>
<tr id="id_b55030d9-067e-4dc0-97d9-5a8f566075bd">
<td align="left" stylecode="Botrule" valign="bottom">20 mg b.i.d.</td>
<td align="center" stylecode="Botrule" valign="top">36</td>
<td align="center" stylecode="Botrule" valign="top">–24</td>
<td align="center" stylecode="Botrule" valign="top">–32</td>
<td align="center" stylecode="Botrule" valign="top">+2</td>
<td align="center" stylecode="Botrule" valign="top">–32</td>
<td align="center" stylecode="Botrule" valign="top">–24</td>
<td align="center" stylecode="Botrule" valign="top">–6</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-520428f1-2cd5-447f-8782-c8505ce65b72-clinicalPharmacology-2.txt'/><table id="id_dd21861a-a79d-4f7f-9516-74d2c719f496" width="692.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_1924d3e2-6f5a-408f-b84b-d4225a0d03ea">TABLE III: MEVACOR vs. Cholestyramine (Percent Change from Baseline After 12 Weeks)</caption>
<col width="14.9%"></col>
<col width="9.0%"></col>
<col width="11.1%"></col>
<col width="11.1%"></col>
<col width="11.1%"></col>
<col width="10.3%"></col>
<col width="11.1%"></col>
<col width="11.1%"></col>
<col width="10.3%"></col>
<thead>
<tr id="id_2b0fddd7-1e26-4688-976a-634c95f687ef">
<td align="left" stylecode="Botrule" valign="top">TREATMENT</td>
<td align="center" stylecode="Botrule" valign="top">N</td>
<td align="center" stylecode="Botrule" valign="top">TOTAL-C<br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="top">LDL-C<br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="top">HDL-C<br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="top">LDL-C/HDL-C<br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="top">TOTAL-C/HDL-C<br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="top">VLDL-C<br/>(median)</td>
<td align="center" stylecode="Botrule" valign="top">TG.<br/>(mean)</td>
</tr>
</thead>
<tbody>
<tr id="id_796de319-eef9-403f-b646-b52fa30af6f9">
<td align="left" colspan="9" valign="top">MEVACOR</td>
</tr>
<tr id="id_5c5bff26-4c62-4746-bd47-6107a7427eaf">
<td align="left" valign="top">20 mg b.i.d.</td>
<td align="center" valign="top">85</td>
<td align="center" valign="top">–27</td>
<td align="center" valign="top">–32</td>
<td align="center" valign="top">+9</td>
<td align="center" valign="top">–36</td>
<td align="center" valign="top">–31</td>
<td align="center" valign="top">–34</td>
<td align="center" valign="top">–21</td>
</tr>
<tr id="id_e7cc0db0-2e70-4723-8d8d-c09487a84671">
<td align="left" valign="top">40 mg b.i.d.<br/>
<br/>
</td>
<td align="center" valign="top">88</td>
<td align="center" valign="top">–34</td>
<td align="center" valign="top">–42</td>
<td align="center" valign="top">+8</td>
<td align="center" valign="top">–44</td>
<td align="center" valign="top">–37</td>
<td align="center" valign="top">–31</td>
<td align="center" valign="top">–27</td>
</tr>
<tr id="id_c2617b67-7db6-4990-8c48-cae6d822e0db">
<td align="left" colspan="9" valign="top">Cholestyramine</td>
</tr>
<tr id="id_358da5b4-5554-432a-bda3-befb7ddf8844">
<td align="left" stylecode="Botrule" valign="top">12 g b.i.d.</td>
<td align="center" stylecode="Botrule" valign="top">88</td>
<td align="center" stylecode="Botrule" valign="top">–17</td>
<td align="center" stylecode="Botrule" valign="top">–23</td>
<td align="center" stylecode="Botrule" valign="top">+8</td>
<td align="center" stylecode="Botrule" valign="top">–27</td>
<td align="center" stylecode="Botrule" valign="top">–21</td>
<td align="center" stylecode="Botrule" valign="top">+2</td>
<td align="center" stylecode="Botrule" valign="top">+11</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-520428f1-2cd5-447f-8782-c8505ce65b72-clinicalPharmacology-3.txt'/><table id="id_7fa433da-248d-464b-8a7a-eb60c9dde3bb" width="642.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_1d5c0c18-5c05-48db-9d5f-701d32952e3f">TABLE IV: MEVACOR vs. Placebo (Percent Change from Baseline — Average Values Between Weeks 12 and 48)</caption>
<col width="14.3%"></col>
<col width="11.4%"></col>
<col width="12.0%"></col>
<col width="12.8%"></col>
<col width="12.8%"></col>
<col width="12.8%"></col>
<col width="13.7%"></col>
<col width="10.3%"></col>
<thead>
<tr id="id_9fcbf1c6-8d23-43ce-9f65-b1ee4ac90fd3">
<td align="left" stylecode="Botrule" valign="bottom">DOSAGE</td>
<td align="center" stylecode="Botrule" valign="bottom">N<footnote id="id-19643a59-ede3-40e8-bf9e-c5fc66132c4e">Patients enrolled</footnote>
</td>
<td align="center" stylecode="Botrule" valign="bottom">TOTAL-C<br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="bottom">LDL-C<br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="bottom">HDL-C<br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="bottom">LDL-C/HDL-C <br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="bottom">TOTAL-C/HDL-C<br/>(mean)</td>
<td align="center" stylecode="Botrule" valign="bottom">TG.<br/>(median)</td>
</tr>
</thead>
<tbody>
<tr id="id_c3513c75-2792-401e-8321-e21d926cdb0a">
<td align="left" stylecode="Toprule" valign="top">Placebo</td>
<td align="center" stylecode="Toprule" valign="top">1663</td>
<td align="center" stylecode="Toprule" valign="top">+0.7</td>
<td align="center" stylecode="Toprule" valign="top">+0.4</td>
<td align="center" stylecode="Toprule" valign="top">+2.0</td>
<td align="center" stylecode="Toprule" valign="top">+0.2</td>
<td align="center" stylecode="Toprule" valign="top">+0.6</td>
<td align="center" valign="top">+4</td>
</tr>
<tr id="id_8a7ba175-02bf-4b02-b3dc-cd8db0e28ba6">
<td align="left" colspan="8" valign="top">
<br/>MEVACOR</td>
</tr>
<tr id="id_8ade2197-e141-4b21-9ad1-86f86829802a">
<td align="left" valign="top">20 mg q.p.m.</td>
<td align="center" valign="top">1642</td>
<td align="center" valign="top">–17</td>
<td align="center" valign="top">–24</td>
<td align="center" valign="top">+6.6</td>
<td align="center" valign="top">–27</td>
<td align="center" valign="top">–21</td>
<td align="center" valign="top">–10</td>
</tr>
<tr id="id_bd5f075b-8cc0-4298-a44b-fd33f4f1f245">
<td align="left" valign="top">40 mg q.p.m.</td>
<td align="center" valign="top">1645</td>
<td align="center" valign="top">–22</td>
<td align="center" valign="top">–30</td>
<td align="center" valign="top">+7.2</td>
<td align="center" valign="top">–34</td>
<td align="center" valign="top">–26</td>
<td align="center" valign="top">–14</td>
</tr>
<tr id="id_e333a777-e2ec-44ec-bd72-7dd7f33ba38a">
<td align="left" valign="top">20 mg b.i.d.</td>
<td align="center" valign="top">1646</td>
<td align="center" valign="top">–24</td>
<td align="center" valign="top">–34</td>
<td align="center" valign="top">+8.6</td>
<td align="center" valign="top">–38</td>
<td align="center" valign="top">–29</td>
<td align="center" valign="top">–16</td>
</tr>
<tr id="id_3531fbb7-8cd5-4f30-a015-44f6a75952ee">
<td align="left" stylecode="Botrule" valign="top">40 mg b.i.d.</td>
<td align="center" stylecode="Botrule" valign="top">1649</td>
<td align="center" stylecode="Botrule" valign="top">–29</td>
<td align="center" stylecode="Botrule" valign="top">–40</td>
<td align="center" stylecode="Botrule" valign="top">+9.5</td>
<td align="center" stylecode="Botrule" valign="top">–44</td>
<td align="center" stylecode="Botrule" valign="top">–34</td>
<td align="center" stylecode="Botrule" valign="top">–19</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-520428f1-2cd5-447f-8782-c8505ce65b72-clinicalPharmacology-4.txt'/><table id="id_b8236259-3f3d-43dd-b4f8-fab4040a0bda" width="625.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_82420b48-41b6-42b9-8a27-731c78be5a82">TABLE V: Lipid-lowering Effects of Lovastatin in Adolescent Boys with Heterozygous Familial Hypercholesterolemia (Mean Percent Change from Baseline at Week 48 in Intention-to-Treat Population)</caption>
<col width="14.9%"></col>
<col width="4.3%"></col>
<col width="14.1%"></col>
<col width="14.9%"></col>
<col width="15.8%"></col>
<col width="15.8%"></col>
<col width="20.2%"></col>
<thead>
<tr id="id_c44568dd-5b4e-487e-8d9f-464767b65ee3">
<td align="left" stylecode="Botrule" valign="bottom">DOSAGE</td>
<td align="center" stylecode="Botrule" valign="bottom">N</td>
<td align="center" stylecode="Botrule" valign="bottom">TOTAL-C</td>
<td align="center" stylecode="Botrule" valign="bottom">LDL-C</td>
<td align="center" stylecode="Botrule" valign="bottom">HDL-C</td>
<td align="center" stylecode="Botrule" valign="bottom">TG.<footnote id="id-c957ccdb-3c90-4fb0-a60d-7e58d3dbca5e">data presented as median percent changes</footnote>
</td>
<td align="center" stylecode="Botrule" valign="bottom">Apolipoprotein B</td>
</tr>
</thead>
<tbody>
<tr id="id_da5c8425-43aa-4e46-9eaf-b3bbebab37c8">
<td align="left" stylecode="Toprule" valign="top">Placebo</td>
<td align="center" stylecode="Toprule" valign="top">61</td>
<td align="center" stylecode="Toprule" valign="top">–1.1</td>
<td align="center" stylecode="Toprule" valign="top">–1.4</td>
<td align="center" stylecode="Toprule" valign="top">–2.2</td>
<td align="center" stylecode="Toprule" valign="top">–1.4</td>
<td align="center" valign="top">–4.4</td>
</tr>
<tr id="id_95444439-8416-4b21-a529-d9db15f8a1ef">
<td align="left" stylecode="Botrule" valign="top">MEVACOR</td>
<td align="center" stylecode="Botrule" valign="top">64</td>
<td align="center" stylecode="Botrule" valign="top">–19.3</td>
<td align="center" stylecode="Botrule" valign="top">–24.2</td>
<td align="center" stylecode="Botrule" valign="top">+1.1</td>
<td align="center" stylecode="Botrule" valign="top">–1.9</td>
<td align="center" stylecode="Botrule" valign="top">–21</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-520428f1-2cd5-447f-8782-c8505ce65b72-clinicalPharmacology-5.txt'/><table id="id_d3cfe69a-b5c6-434e-bbcb-50d8cdc4adad" width="603.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_0f41673f-927e-458a-8746-8015b392603d">TABLE VI: Lipid-lowering Effects of Lovastatin in Post-Menarchal Girls with Heterozygous Familial Hypercholesterolemia (Mean Percent Change from Baseline at Week 24 in Intention-to-Treat Population)</caption>
<col width="17.2%"></col>
<col width="4.5%"></col>
<col width="12.8%"></col>
<col width="13.6%"></col>
<col width="15.4%"></col>
<col width="16.4%"></col>
<col width="20.1%"></col>
<thead>
<tr id="id_bf6bc5b6-cf8c-453e-8cac-6c12ba5e4696">
<td align="left" stylecode="Botrule" valign="bottom">DOSAGE</td>
<td align="center" stylecode="Botrule" valign="bottom">N</td>
<td align="center" stylecode="Botrule" valign="bottom">TOTAL-C</td>
<td align="center" stylecode="Botrule" valign="bottom">LDL-C</td>
<td align="center" stylecode="Botrule" valign="bottom">HDL-C</td>
<td align="center" stylecode="Botrule" valign="bottom">TG.<footnote id="id-6d7e65f1-a069-4548-88d2-f15c36174e7a">data presented as median percent changes</footnote>
</td>
<td align="center" stylecode="Botrule" valign="bottom">Apolipoprotein B</td>
</tr>
</thead>
<tbody>
<tr id="id_fd264f6f-6bb1-4db6-a5aa-e100e91cae5a">
<td align="left" stylecode="Toprule" valign="top">Placebo</td>
<td align="center" stylecode="Toprule" valign="top">18</td>
<td align="center" stylecode="Toprule" valign="top">+3.6</td>
<td align="center" stylecode="Toprule" valign="top">+2.5</td>
<td align="center" stylecode="Toprule" valign="top">+4.8</td>
<td align="center" stylecode="Toprule" valign="top">–3.0</td>
<td align="center" valign="top">+6.4</td>
</tr>
<tr id="id_91e70f76-a550-48bc-b5eb-b4ddf3ee6821">
<td align="left" stylecode="Botrule" valign="top">MEVACOR</td>
<td align="center" stylecode="Botrule" valign="top">35</td>
<td align="center" stylecode="Botrule" valign="top">–22.4</td>
<td align="center" stylecode="Botrule" valign="top">–29.2</td>
<td align="center" stylecode="Botrule" valign="top">+2.4</td>
<td align="center" stylecode="Botrule" valign="top">–22.7</td>
<td align="center" stylecode="Botrule" valign="top">–24.4</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-53664f8d-3a93-9f2b-daee-380707e4062c-clinicalPharmacology-0.txt'/><table width="467.65pt" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 4 COMPARISON OF MEAN (SD) FLUVOXAMINE PHARMACOKINETIC PARAMETERS BETWEEN CHILDREN, ADOLESCENTS, AND ADULTS</caption>
<col width="33%"></col>
<col width="16%"></col>
<col width="16%"></col>
<col width="17%"></col>
<col width="16%"></col>
<tbody>
<tr stylecode="Toprule">
<td align="center" rowspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Pharmacokinetic Parameter (body weight corrected)</content>
</paragraph>
</td>
<td align="center" colspan="2" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Dose = 200 mg/day<br/>(100 mg b.i.d.)</content>
</paragraph>
</td>
<td align="center" colspan="2" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Dose = 300 mg/day<br/>(150 mg b.i.d.)</content>
</paragraph>
</td>
</tr>
<tr stylecode="Toprule">
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">Children<br/>(N = 10)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">Adolescent (N = 17)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">Adolescent (N = 13)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">Adult <br/>(N = 16)</content>
</paragraph>
</td>
</tr>
<tr stylecode="Toprule">
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>AUC 0-12 (ng•h/mL/kg) </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>155.1 (160.9)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>43.9 (27.9)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>69.6 (46.6)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>59.4 (40.9)</paragraph>
</td>
</tr>
<tr stylecode="Toprule">
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>C<sub>max</sub> (ng/mL/kg) </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>14.8 (14.9)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>4.2 (2.6)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>6.7 (4.2)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>5.7 (3.9)</paragraph>
</td>
</tr>
<tr stylecode="Toprule">
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>C<sub>min</sub> (ng/mL/kg) </paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>11 (11.9)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>2.9 (2)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>4.8 (3.8)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>4.6 (3.2)</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-53664f8d-3a93-9f2b-daee-380707e4062c-clinicalPharmacology-1.txt'/><table width="471.4pt" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 5  COMPARISON OF MEAN (SD) FLUVOXAMINE PHARMACOKINETIC PARAMETERS BETWEEN MALE AND FEMALE CHILDREN (6 TO 11 YEARS) </caption>
<col width="33%"></col>
<col width="33%"></col>
<col width="33%"></col>
<tbody>
<tr stylecode="Toprule">
<td align="center" rowspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Pharmacokinetic Parameter (body weight corrected)</content>
</paragraph>
</td>
<td align="center" colspan="2" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Dose = 200 mg/day (100 mg b.i.d.)</content>
</paragraph>
</td>
</tr>
<tr stylecode="Toprule">
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">Male Children<br/>(N = 7)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">Female Children<br/>(N = 3)</content>
</paragraph>
</td>
</tr>
<tr stylecode="Toprule">
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>AUC 0-12 (ng•h/mL/kg) </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>95.8 (83.9)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>293.5 (233)</paragraph>
</td>
</tr>
<tr stylecode="Toprule">
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>C<sub>max</sub> (ng/mL/kg) </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>9.1 (7.6)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>28.1 (21.1)</paragraph>
</td>
</tr>
<tr stylecode="Toprule">
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>C<sub>min</sub> (ng/mL/kg) </paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>6.6 (6.1)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>21.2 (17.6) </paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-5429f134-839f-4ffc-9944-55f51238def8-drugInteractions-0.txt'/><table id="t12" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 12: Clinically Important Drug Interactions with SAPHRIS
</caption>
<col align="left" width="25.500%"></col>
<col align="left" width="44.933%"></col>
<col align="left" width="29.567%"></col>
<tbody>
<tr>
<td align="center" stylecode="Toprule Botrule Lrule Rrule" valign="top">
<content stylecode="bold">Concomitant Drug Name or Drug Class</content>
</td>
<td align="center" stylecode="Toprule Botrule Rrule" valign="top">
<content stylecode="bold">Clinical Rationale</content>
</td>
<td align="center" stylecode="Toprule Botrule Rrule" valign="top">
<content stylecode="bold">Clinical Recommendation</content>
</td>
</tr>
<tr>
<td align="justify" stylecode="Botrule Lrule Rrule" valign="top">Antihypertensive Drugs<br/>
</td>
<td align="justify" stylecode="Botrule Rrule" valign="top">Because of its α<sub>1</sub>-adrenergic antagonism with potential for inducing hypotension, SAPHRIS may enhance the effects of certain antihypertensive agents <content stylecode="italics">[see Warnings and Precautions (<linkhtml href="#s28">5.7</linkhtml>)]</content>.
</td>
<td align="justify" stylecode="Botrule Rrule" valign="top">Monitor blood pressure and adjust dosage of antihypertensive drug accordingly.
</td>
</tr>
<tr>
<td align="justify" stylecode="Botrule Lrule Rrule" valign="top">Strong CYP1A2 Inhibitors (e.g., Fluvoxamine)
</td>
<td align="justify" stylecode="Botrule Rrule" valign="top">SAPHRIS is metabolized by CYP1A2. Marginal increase of asenapine exposure was observed when SAPHRIS is used with fluvoxamine at 25 mg administered twice daily <content stylecode="italics">[see Clinical Pharmacology (<linkhtml href="#s94">12.3</linkhtml>)]</content>. However, the tested fluvoxamine dose was suboptimal. Full therapeutic dose of fluvoxamine is expected to cause a greater increase in asenapine exposure.
</td>
<td align="justify" stylecode="Botrule Rrule" valign="top">Dosage reduction for SAPHRIS based on clinical response may be necessary.
</td>
</tr>
<tr>
<td align="justify" stylecode="Botrule Lrule Rrule" valign="top">CYP2D6 substrates and inhibitors (e.g., paroxetine)
</td>
<td align="justify" stylecode="Botrule Rrule" valign="top">SAPHRIS may enhance the inhibitory effects of paroxetine on its own metabolism. Concomitant use of paroxetine with SAPHRIS increased the paroxetine exposure by 2-fold as compared to use paroxetine alone <content stylecode="italics">[see Clinical Pharmacology (<linkhtml href="#s94">12.3</linkhtml>)].</content>
</td>
<td align="justify" stylecode="Botrule Rrule" valign="top">Reduce paroxetine dose by half when paroxetine is used in combination with SAPHRIS.
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-aad8b373-0aec-4efb-8e61-3d8114b31127-clinicalPharmacology-0.txt'/><table id="id_d04324f3-dfca-4847-aa2a-652c9700077a" width="443" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_a18176c2-c58a-48af-8a92-fb51ddaa1502">Table 3: Effect of Coadministered Drugs on Fluvastatin Systemic Exposure</caption>
<col width="29.7%"></col>
<col width="26.4%"></col>
<col width="22.3%"></col>
<col width="21.5%"></col>
<tbody>
<tr id="id_bc84f283-fd7c-4903-8b6b-a4deff0d8d67" stylecode="Toprule">
<td align="left" stylecode="Botrule Rrule" valign="top">Coadministered drug and dosing regimen</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Fluvastatin </td>
<td align="left" stylecode="Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule" valign="top"></td>
</tr>
<tr id="id_dc62de6a-d225-468d-a097-d8649a58704a">
<td align="left" stylecode="Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Dose (mg)</content>
<footnote id="id-e2ab8ee5-ab79-4e23-ab67-74d0e7ee1d15">Single dose unless otherwise noted </footnote>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Change in AUC</content>
<footnote id="id-8d0bcc13-e344-4146-afe6-f12d74f013e1">Mean ratio (with/without coadministered drug and no change = 1 fold) or % change (with/without coadministered drug and no change = 0%); symbols of ↑ and ↓ indicate the exposure increase and decrease, respectively. </footnote>
</td>
<td align="left" stylecode="Botrule" valign="top">
<content stylecode="bold">Change in C<sub>max</sub>
</content>
<footnoteref idref="id-8d0bcc13-e344-4146-afe6-f12d74f013e1"></footnoteref>
</td>
</tr>
<tr id="id_03c97b51-5285-465a-b684-da40c169fa18">
<td align="left" stylecode="Botrule Rrule" valign="top">Cyclosporine - stable dose (b.i.d.)<footnote id="id-10bbad35-b1d1-4244-babb-a94768470519">Considered clinically significant [<content stylecode="italics">see Dosage and Administration (<linkhtml href="#i4i_dosage_admin_id_0e871e12-e843-4361-9579-7763e877f9bf">2</linkhtml>) and Drug Interactions (<linkhtml href="#i4i_interactions_id_25d02351-69fd-4e29-9276-8e0b77bc6752">7</linkhtml>)</content>]</footnote>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">20 mg QD for 14 weeks</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑90%</td>
<td align="left" stylecode="Botrule" valign="top">↑30%</td>
</tr>
<tr id="id_9d064db5-e68f-402b-b2bd-751c6c5fe83d">
<td align="left" stylecode="Botrule Rrule" valign="top">Fluconazole 400 mg QD day 1,200 mg b.i.d. day 2 to 4<footnoteref idref="id-10bbad35-b1d1-4244-babb-a94768470519"></footnoteref>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">40 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑84%</td>
<td align="left" stylecode="Botrule" valign="top">↑44%</td>
</tr>
<tr id="id_d9f3102f-076d-4e41-9620-f6e85f986ef1">
<td align="left" stylecode="Botrule Rrule" valign="top">Cholestyramine 8 g QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">20 mg QD administered 4 hrs after a meal plus cholestyramine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↓51%</td>
<td align="left" stylecode="Botrule" valign="top">↓83%</td>
</tr>
<tr id="id_793c50bc-27c5-401e-acb8-d02ad81ae9d3">
<td align="left" stylecode="Botrule Rrule" valign="top">Rifampicin 600 mg QD for 6 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">20 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↓53%</td>
<td align="left" stylecode="Botrule" valign="top">↓42%</td>
</tr>
<tr id="id_966f168e-5d49-450c-91af-557d1ff6c700">
<td align="left" stylecode="Botrule Rrule" valign="top">Cimetidine 400 mg b.i.d. for 5 days, QD on Day 6</td>
<td align="left" stylecode="Botrule Rrule" valign="top">20 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑30%</td>
<td align="left" stylecode="Botrule" valign="top">↑40%</td>
</tr>
<tr id="id_8c147918-677a-4852-8506-c0ddeba70339">
<td align="left" stylecode="Botrule Rrule" valign="top">Ranitidine 150 mg b.i.d. for 5 days, QD on Day 6</td>
<td align="left" stylecode="Botrule Rrule" valign="top">20 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑10%</td>
<td align="left" stylecode="Botrule" valign="top">↑50%</td>
</tr>
<tr id="id_ef7f1d29-3d27-4d5d-ada7-51a493c5020c">
<td align="left" stylecode="Botrule Rrule" valign="top">Omeprazole 40 mg QD for 6 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">20 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑20%</td>
<td align="left" stylecode="Botrule" valign="top">↑37%</td>
</tr>
<tr id="id_97514579-d50e-4c35-aebc-f128cc6d963b">
<td align="left" stylecode="Botrule Rrule" valign="top">Phenytoin 300 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">40 mg b.i.d. for 5 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑40%</td>
<td align="left" stylecode="Botrule" valign="top">↑27%</td>
</tr>
<tr id="id_216a458b-fb54-4503-8210-237de17a291d">
<td align="left" stylecode="Botrule Rrule" valign="top">Propranolol 40 mg b.i.d. for 3.5 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">40 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↓5%</td>
<td align="left" stylecode="Botrule" valign="top">No change</td>
</tr>
<tr id="id_b97e65c6-63d2-4a93-aac2-2ee3b28cfe03">
<td align="left" stylecode="Botrule Rrule" valign="top">Digoxin 0.1 to 0.5 mg QD for 3 weeks</td>
<td align="left" stylecode="Botrule Rrule" valign="top">40 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">No change</td>
<td align="left" stylecode="Botrule" valign="top">↑11%</td>
</tr>
<tr id="id_4be3845e-fc8e-4181-80f4-7f118c8fe938">
<td align="left" stylecode="Botrule Rrule" valign="top">Diclofenac 25 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">40 mg QD for 8 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑50%</td>
<td align="left" stylecode="Botrule" valign="top">↑80%</td>
</tr>
<tr id="id_562dca1e-2b80-4034-97ad-9107d69ea129">
<td align="left" stylecode="Botrule Rrule" valign="top">Glyburide 5 to 20 mg QD for 22 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">40 mg b.i.d. for 14 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑51%</td>
<td align="left" stylecode="Botrule" valign="top">↑44%</td>
</tr>
<tr id="id_2ae8ef18-7e95-4961-8060-257ed976a0aa">
<td align="left" stylecode="Botrule Rrule" valign="top">Warfarin 30 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">40 mg QD for 8 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑30%</td>
<td align="left" stylecode="Botrule" valign="top">↑67%</td>
</tr>
<tr id="id_df46af4c-e92a-4a63-8c86-8c609333fc94" stylecode="Botrule">
<td align="left" stylecode="Rrule" valign="top">Clopidogrel 300 mg loading dose on day 10, 75 mg QD on days 11 to 19</td>
<td align="left" stylecode="Rrule" valign="top">fluvastatin sodium extended-release tablets, 80 mg QD for 19 days </td>
<td align="left" stylecode="Rrule" valign="top">↓2%</td>
<td align="left" valign="top">↑27%</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-aad8b373-0aec-4efb-8e61-3d8114b31127-clinicalPharmacology-1.txt'/><table border="single" id="id_1ee97325-86e7-45a1-bcb8-18d80ea63b54" width="446" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_7e85f63e-b828-4fcd-a1c3-20f4658c843d">Table 4: Effect of Fluvastatin Coadministration on Systemic Exposure of Other Drugs</caption>
<col width="29.5%"></col>
<col width="28.3%"></col>
<col width="22.2%"></col>
<col width="20.2%"></col>
<tbody>
<tr id="id_f5dc8b2a-2094-4d60-936e-49f01a53bc93">
<td align="left" stylecode="Botrule Toprule Rrule Lrule" valign="top">Fluvastatin dosage regimen</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Coadministered drug</td>
<td align="left" stylecode="Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule Rrule" valign="top"></td>
</tr>
<tr id="id_f61e0fbc-1160-4c13-b9b3-59d7969806aa">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Name and Dose (mg)</content>
<footnote id="id-ce1512ed-7bf6-40a6-ad74-a9daae347cd8">Single dose unless otherwise noted</footnote>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Change in AUC</content>
<footnote id="id-c7c53674-8559-4346-9dcc-ac45ac6fb3f3">Mean ratio (with/without coadministered drug and no change = 1 fold) or % change (with/without coadministered drug and no change = 0%); symbols of ↑ and ↓ indicate the exposure increase and decrease, respectively. </footnote>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Change in C<sub>max</sub>
</content>
<footnoteref idref="id-c7c53674-8559-4346-9dcc-ac45ac6fb3f3"></footnoteref>
</td>
</tr>
<tr id="id_c5c6d9b4-6b92-494e-b225-848f284ace14">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">40 mg QD for 5 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Phenytoin 300 mg QD<footnote id="id-d31e6a8a-e821-43d4-8f9f-6e2214c7bebc">Considered clinically significant [<content stylecode="italics">see Dosage and Administration (<linkhtml href="#i4i_dosage_admin_id_0e871e12-e843-4361-9579-7763e877f9bf">2</linkhtml>) and Drug Interactions (<linkhtml href="#i4i_interactions_id_25d02351-69fd-4e29-9276-8e0b77bc6752">7</linkhtml>)</content>]        </footnote>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑20%</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑5%</td>
</tr>
<tr id="id_d9f4ed8d-f0eb-4e26-952e-c59b7948b6b6">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">40 mg b.i.d. for 21 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Glyburide 5 to 20 mg QD for 22 days<footnoteref idref="id-d31e6a8a-e821-43d4-8f9f-6e2214c7bebc"></footnoteref>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑70%</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑50%</td>
</tr>
<tr id="id_9c2742c0-6e75-42bf-bc1c-6ac0a9a93e3d">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">40 mg QD for 8 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Diclofenac 25 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑25%</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑60%</td>
</tr>
<tr id="id_3c34bd62-8a15-4cbb-9ec5-a72cb7295d1c">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">40 mg QD for 8 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Warfarin 30 mg QD</td>
<td align="left" stylecode="Botrule Rrule" valign="top">S-warfarin: ↑7%</td>
<td align="left" stylecode="Botrule Rrule" valign="top">S-warfarin: ↑10%</td>
</tr>
<tr id="id_99e60b34-1c4b-4a1b-adb9-6ebc9b411f4f">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule Rrule" valign="top">R-warfarin: no change</td>
<td align="left" stylecode="Botrule Rrule" valign="top">R-warfarin: ↑6%</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-ad386ed4-a284-4da5-b79a-3c0f4165057a-clinicalPharmacology-0.txt'/><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<col></col>
<col></col>
<tbody>
<tr>
<td colspan="3"></td>
</tr>
<tr>
<td rowspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Coadministered Drug and Dosing </content>
</paragraph>
<paragraph>
<content stylecode="bold">Regimen</content>
</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule     "> </td>
<td align="center" colspan="2" stylecode="     Botrule          Toprule          Rrule     ">
<content stylecode="bold">Pravastatin</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Dose (mg)</content>
</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Change in AUC</content>
</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Change in C<sub>max</sub>
</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Cyclosporine 5 mg/kg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>40 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 282%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 327%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Clarithromycin 500 mg BID for 9 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>40 mg OD for 8 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 110%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 128%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Boceprevir 800 mg TID for 6 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>40 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 63%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 49%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Darunavir 600 mg BID/Ritonavir 100 mg BID for 7 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>40 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 81%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 63%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Colestipol 10 g single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 47%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 53%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>Cholestyramine 4 g single dose</paragraph>
</td>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>20 mg single dose</paragraph>
</td>
<td stylecode="     Toprule         Lrule     ">  </td>
<td stylecode="     Toprule         Lrule          Rrule     ">   </td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     ">
<paragraph>Administered simultaneously</paragraph>
</td>
<td rowspan="3" stylecode="     Botrule         Lrule          Rrule     ">  <br/>  <br/>  </td>
<td stylecode="    Lrule     ">
<paragraph>↓ 40%</paragraph>
</td>
<td stylecode="    Lrule          Rrule     ">
<paragraph>↓ 39%</paragraph>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     ">
<paragraph>Administered 1 hour prior to <br/>cholestyramine</paragraph>
</td>
<td stylecode="    Lrule     ">
<paragraph>↑ 12%</paragraph>
</td>
<td stylecode="    Lrule          Rrule     ">
<paragraph>↑ 30%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>Administered 4 hours after<br/>cholestyramine</paragraph>
</td>
<td stylecode="     Botrule         Lrule     ">
<paragraph>↓ 12%</paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>↓ 6.8%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>Cholestyramine 24 g OD for 4 weeks</paragraph>
</td>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>20 mg BID for 8 weeks</paragraph>
</td>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>↓ 51%</paragraph>
</td>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>↑ 4.9%</paragraph>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     ">   </td>
<td stylecode="    Lrule          Rrule     ">
<paragraph>5 mg BID for 8 weeks</paragraph>
</td>
<td stylecode="    Lrule          Rrule     ">
<paragraph>↓ 38% </paragraph>
</td>
<td stylecode="    Lrule          Rrule     ">
<paragraph>↑ 23% </paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     ">   </td>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>10 mg BID for 8 weeks</paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>↓ 18% </paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>↓ 33% </paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>Fluconazole </paragraph>
</td>
<td stylecode="     Toprule         Lrule          Rrule     ">   </td>
<td stylecode="     Toprule         Lrule          Rrule     ">  </td>
<td stylecode="     Toprule         Lrule          Rrule     "> </td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     ">
<paragraph>200 mg IV for 6 days</paragraph>
</td>
<td stylecode="    Lrule          Rrule     ">
<paragraph>20 mg PO + 10 mg IV</paragraph>
</td>
<td stylecode="    Lrule          Rrule     ">
<paragraph>↓ 34%</paragraph>
</td>
<td stylecode="    Lrule          Rrule     ">
<paragraph>↓ 33%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>200 mg PO for 6 days</paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>20 mg PO + 10 mg IV</paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>↓ 16%</paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>↓ 16%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Kaletra 400 mg/100 mg BID for 14 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg OD for 4 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 33%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 26%</paragraph>
</td>
</tr>
<tr>
<td rowspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Verapamil IR 120 mg for 1 day and</paragraph>
<br/>Verapamil ER 480 mg for 3 days</td>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>40 mg single dose</paragraph>
</td>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>↑ 31%</paragraph>
</td>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>↑ 42%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     "> </td>
<td stylecode="     Botrule         Lrule          Rrule     "> </td>
<td stylecode="     Botrule         Lrule          Rrule     "> </td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Cimetidine 300 mg QID for 3 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 30%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 9.8%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Antacids 15 mL QID for 3 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 28%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 24%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Digoxin 0.2 mg OD for 9 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg OD for 9 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 23%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 26%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Probucol 500 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 14%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 24%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Warfarin 5 mg OD for 6 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg BID for 6 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 13%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 6.7%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Itraconazole 200 mg OD for 30 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>40 mg OD for 30 days</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 11% (compared to Day 1)</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 17% (compared to Day 1)</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Gemfibrozil 600 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 7.0%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 20%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Aspirin 324 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 4.7%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑8.9%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Niacin 1 g single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 3.6%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 8.2%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Diltiazem</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 2.7%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 30%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Grapefruit juice</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>40 mg single dose</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↓ 1.8%</paragraph>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 3.7%</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-ad386ed4-a284-4da5-b79a-3c0f4165057a-clinicalPharmacology-1.txt'/><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<col></col>
<col></col>
<tbody>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Pravastatin Dosing</content>
</paragraph>
<paragraph>
<content stylecode="bold">Regimen</content>
</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Name and Dose</content>
</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Change in AUC</content>
</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Change in </content>
</paragraph>
<paragraph>
<content stylecode="bold">C<sub>max</sub>
</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>20 mg BID for 6 days</paragraph>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>Warfarin 5 mg OD for 6 days</paragraph>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>↑ 17%</paragraph>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>↑ 15%</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="     Botrule         Lrule          Rrule     ">  </td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>Change in mean prothrombin time</paragraph>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>↑ 0.4 sec</paragraph>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     "> </td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg OD for 9 days</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Digoxin 0.2 mg OD for 9 days</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 4.6%</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>↑ 5.3%</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>20 mg BID for 4 weeks</paragraph>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>Antipyrine 1.2 g single dose</paragraph>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>↑ 3.0%</paragraph>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>Not Reported</paragraph>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     ">
<paragraph>10 mg BID for 4 weeks</paragraph>
</td>
<td align="center" stylecode="    Lrule          Rrule     ">  </td>
<td align="center" stylecode="    Lrule          Rrule     ">
<paragraph>↑ 1.6% </paragraph>
</td>
<td align="center" stylecode="    Lrule          Rrule     "> </td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>5 mg BID for 4 weeks</paragraph>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     ">  </td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     ">
<paragraph>↑ Less than 1%</paragraph>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     "> </td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>20 mg OD for 4 days</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>Kaletra 400 mg/100 mg BID for 14 days</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>No change</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>No change</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-b074f950-246a-41f0-aedf-32f38998a4b1-clinicalPharmacology-0.txt'/><table id="_RefIDA349970E85AF442DA00BB86A77E54352" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3. Pharmacokinetics in Healthy Adult Subjects Administered a Single Dose of ADASUVE 10 mg  </caption>
<col width="36%"></col>
<col width="29%"></col>
<tbody>
<tr>
<td rowspan="2" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Parameter</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Healthy Subjects</content>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">ADASUVE 10 mg (N=114)</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> AUC<sub>0-2h</sub> (ng•h/mL), mean ± SD </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph> 66.7 ± 18.2 </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> AUC<sub>inf</sub> (ng•h/mL), mean ± SD </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph> 188 ± 47 </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> C<sub>max</sub> (ng/mL), mean ± SD </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph> 257 ± 219 </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> T<sub>max</sub> (minutes), median (25%, 75%) </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph> 1.13 (1, 2) </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph> Half-life(h), mean ± SD </paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph> 7.61 ± 1.87 </paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-b891bd9f-fdb8-4862-89c5-ecdd700398a3-clinicalPharmacology-0.txt'/><table cellpadding="0pt" id="_RefID0EEKBG" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6. Steady State Selegiline Trough Concentrations Associated with Administration of EMSAM 15 mg/15 cm<sup>2</sup> Daily for 7 Days</caption>
<col width="21%"></col>
<col width="38%"></col>
<col width="41%"></col>
<tbody>
<tr>
<td align="center" colspan="3" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Trough Concentration, pg/mL</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule " valign="middle"></td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="bold">6 to 11 year old age group</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="bold">12 to 14 year old age group</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule " valign="middle"></td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>(N = 6)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>(N = 4)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="middle">
<paragraph>
<content stylecode="bold">Mean (SD)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule " valign="middle">
<paragraph>2,562 (974)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule " valign="middle">
<paragraph>1,821 (146)</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-b891bd9f-fdb8-4862-89c5-ecdd700398a3-drugInteractions-0.txt'/><table cellpadding="0pt" id="_RefID0EFPAG" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 5. Food and Beverages to Avoid and Those which are Acceptable<footnote id="_Ref398291227">
<content stylecode="italics">[see <linkhtml href="#ID_5e1c4adc-84ca-4adc-b7fd-8d20157d79a8">References (15)</linkhtml>]</content>
</footnote>
</caption>
<col width="16%"></col>
<col width="40%"></col>
<col width="43%"></col>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Class of Food and Beverage</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Tyramine-Rich Foods and Beverages to Avoid</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Acceptable Foods and Drinks,</content>
</paragraph>
<paragraph>
<content stylecode="bold">Containing No or Little Tyramine</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="underline">Meat, Poultry, and Fish</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage,<br/>and cooked sliced ham)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="underline">Vegetables</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Broad bean pods (fava bean pods)</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>All other vegetables</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="underline">Dairy</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Aged cheeses</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Processed cheeses, mozzarella, ricotta cheese, cottage cheese, and yogurt</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="underline">Beverages</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>All varieties of tap beer and beers that have not been pasteurized so as to allow for ongoing fermentation</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Concomitant use of alcohol with EMSAM is not recommended. (Bottled and canned beers and wines contain little or no tyramine.)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>
<content stylecode="underline">Miscellaneous</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>Concentrated yeast extract (e.g., Marmite), sauerkraut, most soybean products (including soy sauce and tofu), OTC supplements containing tyramine</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>Brewer’s yeast, baker’s yeast, soy milk, commercial chain restaurant pizzas prepared with cheeses low in tyramine</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-ba74e3cd-b06f-4145-b284-5fd6b84ff3c9-clinicalPharmacology-0.txt'/><table border="0" cellpadding="2" cellspacing="1" id="t7173122" width="75%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6 Impact of Renal Impairment on Dabigatran Pharmacokinetics</caption>
<colgroup>
<col align="center" width="19%"></col>
<col align="center" width="19%"></col>
<col align="center" width="20%"></col>
<col align="center" width="19%"></col>
<col align="center" width="20%"></col>
</colgroup>
<tfoot>
<tr>
<td align="left" colspan="5">
<sup>+</sup>Patients
with severe renal impairment were not studied in RE-LY and RE-COVER.
 Dosing recommendations in subjects with severe renal impairment are
based on pharmacokinetic modeling <content stylecode="italics">[see Dosage and Administration <linkhtml href="#Section_2.1">(2.1</linkhtml>, <linkhtml href="#Section_2.2">2.2)</linkhtml> and Use in Specific Populations <linkhtml href="#Section_8.6">(8.6)</linkhtml>]</content>.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Rrule Toprule Lrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Renal Function</content>
</content>
</td>
<td stylecode="Rrule Toprule Lrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">CrCl (mL/min)</content>
</content>
</td>
<td stylecode="Rrule Toprule Lrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Increase in
AUC</content>
</content>
</td>
<td stylecode="Rrule Toprule Lrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Increase in
C<sub>max</sub>
</content>
</content>
</td>
<td stylecode="Rrule Toprule Lrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">t<sub>1/2</sub>
<br/>(h)</content>
</content>
</td>
</tr>
<tr>
<td stylecode="Rrule Toprule Lrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Normal</content>
</content>
</td>
<td stylecode="Rrule Toprule Lrule Botrule">≥ 80</td>
<td stylecode="Rrule Toprule Lrule Botrule">1x</td>
<td stylecode="Rrule Toprule Lrule Botrule">1x</td>
<td stylecode="Rrule Toprule Lrule Botrule">13</td>
</tr>
<tr>
<td stylecode="Rrule Toprule Lrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Mild</content>
</content>
</td>
<td stylecode="Rrule Toprule Lrule Botrule">50-80</td>
<td stylecode="Rrule Toprule Lrule Botrule">1.5x</td>
<td stylecode="Rrule Toprule Lrule Botrule">1.1x</td>
<td stylecode="Rrule Toprule Lrule Botrule">15</td>
</tr>
<tr>
<td stylecode="Rrule Toprule Lrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Moderate</content>
</content>
</td>
<td stylecode="Rrule Toprule Lrule Botrule">30-50</td>
<td stylecode="Rrule Toprule Lrule Botrule">3.2x</td>
<td stylecode="Rrule Toprule Lrule Botrule">1.7x</td>
<td stylecode="Rrule Toprule Lrule Botrule">18</td>
</tr>
<tr>
<td stylecode="Rrule Toprule Lrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Severe<sup>+</sup>
</content>
</content>
</td>
<td stylecode="Rrule Toprule Lrule Botrule">15-30</td>
<td stylecode="Rrule Toprule Lrule Botrule">6.3x</td>
<td stylecode="Rrule Toprule Lrule Botrule">2.1x</td>
<td stylecode="Rrule Toprule Lrule Botrule">27</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-c6e131fe-e7df-4876-83f7-9156fc4e8228-clinicalPharmacology-0.txt'/><table id="table3" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 3. Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin</caption>
<col align="left" valign="middle" width="40%"></col>
<col align="left" valign="middle" width="30%"></col>
<col align="left" valign="middle" width="15%"></col>
<col align="left" valign="middle" width="15%"></col>
<thead>
<tr stylecode="Botrule">
<th align="center" stylecode="Lrule Rrule">Co-administered drug and dosing regimen</th>
<th align="center" colspan="3" stylecode="Rrule" valign="top">Atorvastatin</th>
</tr>
<tr>
<th stylecode="Lrule Rrule"></th>
<th stylecode="Rrule" valign="top">Dose (mg)</th>
<th stylecode="Rrule">Change  in AUC<footnote id="t3ft1"> Data given as x-fold change represent a simple ratio between co-administration and atorvastatin alone (i.e., 1-fold = no change). Data given as % change represent % difference relative to atorvastatin alone (i.e., 0% = no change).</footnote>
</th>
<th stylecode="Rrule">Change in Cmax<footnoteref idref="t3ft1"></footnoteref>
</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnote id="t3ft2">See Sections <linkhtml href="#S5.1">5.1</linkhtml> and <linkhtml href="#S7">7</linkhtml> for clinical significance.</footnote>Cyclosporine 5.2 mg/kg/day, stable dose </td>
<td stylecode="Rrule">10 mg QD for 28 days</td>
<td stylecode="Rrule">↑ 8.7 fold</td>
<td stylecode="Rrule">↑ 10.7 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Tipranavir 500 mg BID/ritonavir 200 mg BID, 7 days</td>
<td stylecode="Rrule">10 mg, SD</td>
<td stylecode="Rrule">↑ 9.4 fold</td>
<td stylecode="Rrule">↑ 8.6 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Telaprevir 750 mg q8h, 10 days</td>
<td stylecode="Rrule">20 mg, SD</td>
<td stylecode="Rrule">↑ 7.88 fold</td>
<td stylecode="Rrule">↑ 10.6 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>
<sup>, </sup>
<footnote id="t3fn3">The dose of saquinavir plus ritonavir in this study is not the clinically used dose. The increase in atorvastatin exposure when used clinically is likely to be higher than what was observed in this study. Therefore, caution should be applied and the lowest dose necessary should be used.</footnote>Saquinavir 400 mg BID/ ritonavir 400mg BID, 15 days </td>
<td stylecode="Rrule">40 mg QD for 4 days</td>
<td stylecode="Rrule">↑ 3.9 fold</td>
<td stylecode="Rrule">↑ 4.3 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Clarithromycin 500 mg BID, 9 days</td>
<td stylecode="Rrule">80 mg QD for 8 days</td>
<td stylecode="Rrule">↑ 4.4 fold</td>
<td stylecode="Rrule">↑ 5.4 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Darunavir 300 mg BID/ritonavir 100 mg BID, 9 days</td>
<td stylecode="Rrule">10 mg QD for 4 days</td>
<td stylecode="Rrule">↑ 3.4 fold</td>
<td stylecode="Rrule">↑ 2.25 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Itraconazole 200 mg QD, 4 days </td>
<td stylecode="Rrule">40 mg SD</td>
<td stylecode="Rrule">↑ 3.3 fold</td>
<td stylecode="Rrule">↑ 20%  </td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days</td>
<td stylecode="Rrule">10 mg QD for 4 days</td>
<td stylecode="Rrule">↑ 2.53 fold</td>
<td stylecode="Rrule">↑ 2.84 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Fosamprenavir 1400 mg BID, 14 days</td>
<td stylecode="Rrule">10 mg QD for 4 days</td>
<td stylecode="Rrule">↑ 2.3 fold</td>
<td stylecode="Rrule">↑ 4.04 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Nelfinavir 1250 mg BID, 14 days</td>
<td stylecode="Rrule">10 mg QD for 28 days</td>
<td stylecode="Rrule">↑ 74%</td>
<td stylecode="Rrule">↑ 2.2 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Grapefruit Juice, 240 mL QD <footnote>Greater increases in AUC (up to 2.5 fold) and/or Cmax (up to 71%) have been reported with excessive grapefruit consumption (≥ 750 mL – 1.2 liters per day).</footnote>
</td>
<td stylecode="Rrule">40 mg, SD</td>
<td stylecode="Rrule">↑ 37%</td>
<td stylecode="Rrule">↑ 16%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Diltiazem 240 mg QD, 28 days </td>
<td stylecode="Rrule">40 mg, SD</td>
<td stylecode="Rrule">↑ 51%</td>
<td stylecode="Rrule">No change</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Erythromycin 500 mg QID, 7 days </td>
<td stylecode="Rrule">10 mg, SD</td>
<td stylecode="Rrule">↑ 33%</td>
<td stylecode="Rrule">↑ 38%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Amlodipine 10 mg, single dose </td>
<td stylecode="Rrule">80 mg, SD</td>
<td stylecode="Rrule">↑ 15%</td>
<td stylecode="Rrule">↓ 12 %</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Cimetidine 300 mg QID, 2 weeks </td>
<td stylecode="Rrule">10 mg QD for 2 weeks</td>
<td stylecode="Rrule">↓ Less than 1%</td>
<td stylecode="Rrule">↓ 11%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Colestipol 10 mg BID, 28 weeks </td>
<td stylecode="Rrule">40 mg QD for 28 weeks</td>
<td stylecode="Rrule">Not determined</td>
<td stylecode="Rrule">↓ 26%<footnote>Single sample taken 8–16 h post dose.</footnote>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Maalox TC® 30 mL QD, 17 days </td>
<td stylecode="Rrule">10 mg QD for 15 days</td>
<td stylecode="Rrule">↓ 33%</td>
<td stylecode="Rrule">↓ 34%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Efavirenz 600 mg QD, 14 days </td>
<td stylecode="Rrule">10 mg for 3 days</td>
<td stylecode="Rrule">↓ 41%</td>
<td stylecode="Rrule">↓ 1%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Rifampin 600 mg QD, 7 days (co-administered) <footnote id="t3ft5">Due to the dual interaction mechanism of rifampin, simultaneous co-administration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations.</footnote>
</td>
<td stylecode="Rrule">40 mg SD</td>
<td stylecode="Rrule">↑ 30%</td>
<td stylecode="Rrule">↑ 2.7 fold</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Rifampin 600 mg QD, 5 days (doses separated) <footnoteref idref="t3ft5"></footnoteref>
</td>
<td stylecode="Rrule">40 mg SD</td>
<td stylecode="Rrule">↓ 80%</td>
<td stylecode="Rrule">↓ 40%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Gemfibrozil 600mg BID, 7 days </td>
<td stylecode="Rrule">40mg SD  </td>
<td stylecode="Rrule">↑ 35%</td>
<td stylecode="Rrule">↓ Less than 1%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<footnoteref idref="t3ft2"></footnoteref>Fenofibrate 160mg QD, 7 days</td>
<td stylecode="Rrule">40mg SD       </td>
<td stylecode="Rrule">↑ 3%</td>
<td stylecode="Rrule">↑ 2%</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Boceprevir 800 mg TID, 7 days</td>
<td stylecode="Rrule">40 mg SD</td>
<td stylecode="Rrule">↑2.30 fold</td>
<td stylecode="Rrule">↑2.66 fold</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-c6e131fe-e7df-4876-83f7-9156fc4e8228-clinicalPharmacology-1.txt'/><table id="table4" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 4. Effect of Atorvastatin on the Pharmacokinetics of Co-administered Drugs</caption>
<col align="left" valign="top" width="25%"></col>
<col align="left" valign="top" width="25%"></col>
<col align="left" valign="top" width="25%"></col>
<col align="left" valign="top" width="25%"></col>
<thead>
<tr stylecode="Botrule">
<th align="center" stylecode="Lrule Rrule">Atorvastatin</th>
<th align="center" colspan="3" stylecode="Rrule">Co-administered drug and dosing regimen</th>
</tr>
<tr>
<th stylecode="Lrule Rrule"></th>
<th stylecode="Rrule">Drug/Dose (mg)</th>
<th stylecode="Rrule">Change  in AUC</th>
<th stylecode="Rrule">Change in Cmax</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">80 mg QD for 15 days </td>
<td stylecode="Rrule">Antipyrine, 600 mg SD</td>
<td stylecode="Rrule">↑ 3%</td>
<td stylecode="Rrule">↓ 11%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">80 mg QD for 14 days</td>
<td stylecode="Rrule">
<footnote>See <linkhtml href="#S7">Section 7</linkhtml> for clinical significance.</footnote> Digoxin 0.25 mg QD, 20 days</td>
<td stylecode="Rrule">↑ 15%</td>
<td stylecode="Rrule">↑ 20 %</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">40 mg QD for 22 days </td>
<td stylecode="Rrule">Oral contraceptive QD,  2 months<br/> - norethindrone 1mg<br/> - ethinyl estradiol 35µg</td>
<td stylecode="Rrule" valign="bottom">
<br/> ↑ 28%<br/> ↑ 19%</td>
<td stylecode="Rrule" valign="bottom">
<br/> ↑ 23%<br/> ↑ 30%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="middle">10 mg, SD</td>
<td stylecode="Rrule" valign="middle">Tipranavir 500 mg BID/ritonavir 200 mg BID, 7 days</td>
<td stylecode="Rrule" valign="middle">No change</td>
<td stylecode="Rrule" valign="middle">No change</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="middle">10 mg QD for 4 days</td>
<td stylecode="Rrule" valign="middle">Fosamprenavir 1400 mg BID, 14 days</td>
<td stylecode="Rrule" valign="middle">↓ 27%</td>
<td stylecode="Rrule" valign="middle">↓ 18%</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="middle">10 mg QD for 4 days</td>
<td stylecode="Rrule" valign="middle">Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days</td>
<td stylecode="Rrule" valign="middle">No change</td>
<td stylecode="Rrule" valign="middle">No change</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-c6e131fe-e7df-4876-83f7-9156fc4e8228-drugInteractions-0.txt'/><table width="90%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (<linkhtml href="#S2.6">2.6</linkhtml>, <linkhtml href="#S5.1">5.1</linkhtml>, <linkhtml href="#S7">7</linkhtml>, <linkhtml href="#S12.3">12.3</linkhtml>)</caption>
<col align="left" valign="top" width="50%"></col>
<col align="left" valign="top" width="50%"></col>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Rrule">Interacting Agents </td>
<td>Prescribing Recommendations </td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Rrule">Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir)</td>
<td valign="middle">Avoid atorvastatin</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Rrule">HIV protease inhibitor (lopinavir plus ritonavir)</td>
<td valign="middle">Use with caution and lowest dose necessary</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Rrule">Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir)</td>
<td valign="middle">Do not exceed 20 mg atorvastatin daily</td>
</tr>
<tr>
<td stylecode="Rrule" valign="middle">HIV protease inhibitor (nelfinavir)<br/>Hepatitis C protease inhibitor (boceprevir)</td>
<td valign="middle">Do not exceed 40 mg atorvastatin daily</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-d2f6d2d0-1b32-4caf-9fce-6b798c94204b-drugInteractions-0.txt'/><table border="0" cellpadding="2" cellspacing="1" id="t2" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2:   Examples of CYP450 Interactions with Warfarin</caption>
<colgroup>
<col width="15%"></col>
<col width="56%"></col>
<col width="29%"></col>
</colgroup>
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule Toprule Botrule">
<content stylecode="bold">Enzyme</content>
</th>
<th align="center" stylecode="Lrule Rrule Toprule Botrule">
<content stylecode="bold">Inhibitors</content>
</th>
<th align="center" stylecode="Lrule Rrule Toprule Botrule">
<content stylecode="bold">Inducers</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">CYP2C9</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">aprepitant, bosentan, carbamazepine, phenobarbital, rifampin</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">CYP1A2</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">CYP3A4</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">alprazolam, amiodarone, amlodipine, amprenavir, 
aprepitant, atorvastatin, atazanavir, bicalutamide, cilostazol, cimetidine, ciprofloxacin, clarithromycin, conivaptan, cyclosporine, darunavir/ritonavir, diltiazem, erythromycin, fluconazole, fluoxetine, fluvoxamine, fosamprenavir, imatinib, indinavir, isoniazid, itraconazole, ketoconazole, lopinavir/ritonavir, nefazodone, nelfinavir, nilotinib, oral contraceptives, posaconazole, ranitidine, ranolazine, ritonavir, saquinavir, telithromycin, tipranavir, voriconazole, zileuton</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">armodafinil, amprenavir, aprepitant, bosentan, carbamazepine, efavirenz, etravirine, modafinil, nafcillin, phenytoin, pioglitazone, prednisone, rifampin, rufinamide</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-d2f6d2d0-1b32-4caf-9fce-6b798c94204b-drugInteractions-1.txt'/><table border="0" cellpadding="2" cellspacing="1" id="t3" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3:   Drugs that Can Increase the Risk of Bleeding</caption>
<colgroup>
<col width="38%"></col>
<col width="62%"></col>
</colgroup>
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule Toprule Botrule">
<content stylecode="bold">Drug Class</content>
</th>
<th align="center" stylecode="Lrule Rrule Toprule Botrule">
<content stylecode="bold">Specific Drugs</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">Anticoagulants</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">argatroban, dabigatran, bivalirudin, desirudin, heparin, lepirudin</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">Antiplatelet Agents</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">aspirin, cilostazol, clopidogrel, dipyridamole, prasugrel, ticlopidine</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">Nonsteroidal Anti-Inflammatory Agents</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">celecoxib, diclofenac, diflunisal, fenoprofen, ibuprofen, indomethacin, ketoprofen, ketorolac, mefenamic acid, naproxen, oxaprozin, piroxicam, sulindac</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">Serotonin Reuptake Inhibitors</td>
<td stylecode="Lrule Rrule Toprule Botrule" valign="top">citalopram, desvenlafaxine, duloxetine, escitalopram, fluoxetine, fluvoxamine, milnacipran, paroxetine, sertraline, venlafaxine, vilazodone</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-d78e9639-6fab-4a78-8b29-6991a18ae6c6-clinicalPharmacology-0.txt'/><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<col></col>
<tbody>
<tr>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">
<paragraph>
<content stylecode="bold">Parameter</content> </paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">
<paragraph>
<content stylecode="bold">Perphenazine</content> </paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">
<paragraph>
<content stylecode="bold">7-Hydroxyperphenazine</content> </paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">
<paragraph>C<sub>max</sub> (pg/mL) </paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">
<paragraph>984 (43) </paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">
<paragraph>509 (25) </paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">
<paragraph>C<sub>min</sub> (pg/mL) </paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">
<paragraph>442 (76) </paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">
<paragraph>350 (56) </paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6-drugInteractions-0.txt'/><table width="75%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="64%"></col>
<col width="23%"></col>
<thead>
<tr>
<th align="left" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<content stylecode="bold">Factors</content>
</th>
<th align="left" stylecode="Rrule Botrule Toprule " valign="top">
<content stylecode="bold">Adjusted Dose</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="2" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">CYP2D6 Poor Metabolizers </content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>CYP2D6 Poor Metabolizers taking concomitant CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>200 mg<footnote id="_Ref400443157">200 mg and 160 mg dose adjustments are obtained only by using the 300 mg or 400 mg strength vials.</footnote>
</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Patients Taking 400 mg of ABILIFY MAINTENA</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Strong CYP2D6 <content stylecode="bold">
<content stylecode="underline">or</content>
</content> CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>300 mg</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>CYP2D6 <content stylecode="bold">
<content stylecode="underline">and</content>
</content> CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>200 mg<footnoteref idref="_Ref400443157"></footnoteref>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>CYP3A4 inducers</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Avoid use</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Patients Taking 300 mg of ABILIFY MAINTENA</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Strong CYP2D6 <content stylecode="bold">
<content stylecode="underline">or</content>
</content> CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>200 mg<footnoteref idref="_Ref400443157"></footnoteref>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>CYP2D6 <content stylecode="bold">
<content stylecode="underline">and</content>
</content> CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>160 mg<footnoteref idref="_Ref400443157"></footnoteref>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>CYP3A4 inducers</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Avoid use</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6-drugInteractions-1.txt'/><table width="441.9pt" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="20%"></col>
<col width="37%"></col>
<col width="36%"></col>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Concomitant Drug Name or Drug Class</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Clinical Rationale</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Clinical Recommendation</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Strong CYP3A4 Inhibitors (e.g., ketoconazole) or strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine) </paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>The concomitant use of oral aripiprazole with strong CYP 3A4 or CYP2D6 inhibitors increased the exposure of aripiprazole<br/>
<content stylecode="italics">[see <linkhtml href="#S12.3">CLINICAL PHARMACOLOGY (12.3)</linkhtml>].</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>With concomitant use of ABILIFY MAINTENA with a strong CYP3A4 inhibitor or CYP2D6 inhibitor for more than 14 days, reduce the ABILIFY MAINTENA dosage <br/>
<content stylecode="italics">[see <linkhtml href="#S2.3">DOSAGE AND ADMINISTRATION (2.3)]. </linkhtml>
</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Strong CYP3A4 Inducers (e.g., carbamazepine)</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>The concomitant use of oral aripiprazole and carbamazepine decreased the exposure of aripiprazole <content stylecode="italics">[see <linkhtml href="#S12.3">CLINICAL PHARMACOLOGY (12.3)</linkhtml>].</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>Avoid use of ABILIFY MAINTENA in combination with carbamazepine and other inducers of CYP3A4 for greater than 14 days <content stylecode="italics">[see <linkhtml href="#_RefS2.3">DOSAGE AND ADMINISTRATION (2.3)</linkhtml>]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Antihypertensive Drugs</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>Due to its alpha adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents.</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>Monitor blood pressure and adjust dose accordingly <content stylecode="italics">[see <linkhtml href="#S5.6">WARNINGS AND PRECAUTIONS (5.6)</linkhtml>].  </content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>Benzodiazepines (e.g., lorazepam)</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>The intensity of sedation was greater with the combination of oral aripiprazole and lorazepam as compared to that observed with aripiprazole alone. The orthostatic hypotension observed was greater with the combination as compared to that observed with lorazepam alone <content stylecode="italics">[see  <linkhtml href="#S5.7">WARNINGS AND PRECAUTIONS  (5.7)</linkhtml>].</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>Monitor sedation and blood pressure. Adjust dose accordingly.</paragraph>
</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-efef4846-9497-41af-8dd6-518f86eca7f2-clinicalPharmacology-0.txt'/><table width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col align="left" width="20%"></col>
<col align="left" width="20%"></col>
<col align="left" width="20%"></col>
<col align="left" width="20%"></col>
<thead>
<tr>
<th align="center" colspan="4">Zone Diameter, nearest whole mm</th>
</tr>
<tr>
<th></th>
<th stylecode="underline" valign="bottom">Susceptible</th>
<th stylecode="underline">Moderately<br/>Susceptible</th>
<th stylecode="underline" valign="bottom">Resistant</th>
</tr>
</thead>
<tbody>
<tr>
<td>Staphylococci</td>
<td>≥29</td>
<td>–</td>
<td>≤28</td>
</tr>
<tr>
<td stylecode="italics">N. gonorrhoeae</td>
<td>≥20</td>
<td>–</td>
<td>≤19</td>
</tr>
<tr>
<td>Enterococci</td>
<td>–</td>
<td>≥15</td>
<td>≤14</td>
</tr>
<tr>
<td>Non-enterococcal streptococci and<content stylecode="italics"> L. monocytogenes</content>
</td>
<td>≥28</td>
<td>20–27</td>
<td>≤19</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-efef4846-9497-41af-8dd6-518f86eca7f2-clinicalPharmacology-1.txt'/><table width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col align="left" width="30%"></col>
<col align="left" width="25%"></col>
<col align="left" width="25%"></col>
<thead>
<tr>
<th align="center" colspan="3">Approximate MIC Correlates</th>
</tr>
<tr>
<th></th>
<th stylecode="underline">Susceptible</th>
<th stylecode="underline">Resistant</th>
</tr>
</thead>
<tbody>
<tr>
<td>Staphylococci</td>
<td>≤0.1 µg/mL</td>
<td>β-lactamase</td>
</tr>
<tr>
<td stylecode="italics">N. gonorrhoeae</td>
<td>≤0.1 µg/mL</td>
<td>β-lactamase</td>
</tr>
<tr>
<td>Enterococci</td>
<td>–</td>
<td>≥16 µg/mL</td>
</tr>
<tr>
<td>Non-enterococcal streptococci and <content stylecode="italics">L. monocytogenes</content>
</td>
<td>≤0.12 µg/mL</td>
<td>≥ 4 µg/mL</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-efef4846-9497-41af-8dd6-518f86eca7f2-clinicalPharmacology-2.txt'/><table width="60%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col align="left" width="30%"></col>
<col align="left" width="30%"></col>
<thead>
<tr>
<th>Control Organism</th>
<th>Zone of Inhibition Range</th>
</tr>
</thead>
<tbody>
<tr>
<td>Staphylococcus aureus<br/>(ATCC 25923)</td>
<td>27–35</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-fdbfe194-b845-42c5-bb87-a48118bc72e7-clinicalPharmacology-0.txt'/><table id="id_5436d4b9-11c3-4e61-9982-0218c30bae8f" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_5a4cf0e4-f7b5-46ab-ba38-67287956b6f6">Table 3: Effect of Coadministered Drugs or Grapefruit Juice on Simvastatin Systemic Exposure</caption>
<col align="left" valign="top" width="18%"></col>
<col align="center" valign="top" width="18%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="left" valign="top" width="19%"></col>
<col align="center" valign="top" width="11%"></col>
<col align="center" valign="top" width="19%"></col>
<thead>
<tr id="id_f16b3778-ee67-49d7-b16c-f0eca7c85d95">
<th align="center" rowspan="2" stylecode="Botrule Toprule Lrule Rrule" valign="middle">Coadministered Drug <br/>or Grapefruit Juice</th>
<th align="center" rowspan="2" stylecode="Botrule Rrule" valign="middle">Dosing of Coadministered Drug or Grapefruit Juice</th>
<th align="center" rowspan="2" stylecode="Botrule Rrule" valign="middle">Dosing of <br/>Simvastatin</th>
<th align="center" colspan="3" stylecode="Rrule Botrule" valign="top">Geometric Mean Ratio<br/>(Ratio<footnote id="id-5410028d-e2bf-4158-b6a9-c9703a3f139d">Results based on a chemical assay except results with propranolol as indicated.</footnote> with / without <br/>coadministered drug)<br/>No Effect = 1.00</th>
</tr>
<tr id="id_73db7827-b393-4fbb-a461-999be941203f">
<th align="center" stylecode="Botrule Rrule" valign="top"></th>
<th align="center" stylecode="Botrule Rrule" valign="top">AUC</th>
<th align="center" stylecode="Botrule Rrule" valign="top">C<sub>max</sub>
</th>
</tr>
</thead>
<tbody>
<tr id="id_838bf4ab-9dee-4acd-8919-79aee94dabd4">
<td align="left" colspan="6" stylecode="Lrule Rrule Botrule" valign="top">
<content stylecode="bold">Contraindicated with simvastatin </content>
<content stylecode="italics">[see <linkhtml href="#i4i_contraindications_id_4075f374-1aea-404c-b31c-2d2ce98df9d2">Contraindications (4)</linkhtml> and <linkhtml href="#i4i_section_id_4fd678af-6eb7-455f-bcb8-e75468f55ff2">Warnings and Precautions (5.1)</linkhtml>]</content>
</td>
</tr>
<tr id="id_a0e9548c-f3b6-4578-b5b8-7811e1b6f574">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Telithromycin<footnote id="id-585996b8-8cba-4869-a63d-cacd344a5b69">Results could be representative of the following CYP3A4 inhibitors: ketoconazole, erythromycin, clarithromycin, HIV protease inhibitors, and nefazodone.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">200 mg QD for 4 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">80 mg</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid<footnote id="id-c7c93f94-3422-4a92-8c31-f21b8f27025c">Simvastatin acid refers to the β-hydroxyacid of simvastatin.</footnote>
<br/>simvastatin </td>
<td align="center" stylecode="Botrule Rrule" valign="top">12<br/>8.9</td>
<td align="center" stylecode="Botrule Rrule" valign="top">15<br/>5.3</td>
</tr>
<tr id="id_f4a71017-b8e2-48c1-9a53-5c3e9f0056e7">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Nelfinavir<footnoteref idref="id-585996b8-8cba-4869-a63d-cacd344a5b69"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">1250 mg BID for 14 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">20 mg QD for 28 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid<footnoteref idref="id-c7c93f94-3422-4a92-8c31-f21b8f27025c"></footnoteref>
<br/>simvastatin </td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<br/>6</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<br/>6.2</td>
</tr>
<tr id="id_4567ccfe-655f-4db8-941f-9470f5fa3d08">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Itraconazole<footnoteref idref="id-585996b8-8cba-4869-a63d-cacd344a5b69"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">200 mg QD for 4 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">80 mg</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid<footnoteref idref="id-c7c93f94-3422-4a92-8c31-f21b8f27025c"></footnoteref>
<br/>simvastatin </td>
<td align="center" stylecode="Botrule Rrule" valign="top"></td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>13.1</paragraph>13.1</td>
</tr>
<tr id="id_683db204-c6e7-4eb5-9685-c0dbd0de41ce">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Posaconazole</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>100 mg (oral suspension)</paragraph>
<paragraph>QD for 13 days<br/>
</paragraph>
<br/>
<paragraph>200 mg (oral suspension)</paragraph>QD for 13 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>40 mg<br/>
</paragraph>
<br/>
<br/>
<paragraph>
<br/>40 mg</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>simvastatin acid <br/>simvastatin</paragraph>
<br/>
<paragraph>
<br/>simvastatin acid <br/>simvastatin</paragraph>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>7.3</paragraph>
<paragraph>10.3</paragraph>
<br/>
<br/>
<paragraph>8.5</paragraph>10.6</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>9.2</paragraph>
<paragraph>9.4</paragraph>
<br/>
<br/>
<paragraph>9.5</paragraph>11.4</td>
</tr>
<tr id="id_6f585143-860a-41bd-9e33-512ecc8a8117">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Gemfibrozil</td>
<td align="center" stylecode="Botrule Rrule" valign="top">600 mg BID for 3 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">40 mg</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid <br/>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>2.85</paragraph>1.35</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>2.18</paragraph>0.91</td>
</tr>
<tr id="id_a9bf5471-8e9b-42d1-abe4-6b574eb4431b">
<td align="left" colspan="6" stylecode="Lrule Rrule Botrule" valign="top">
<content stylecode="bold">Avoid grapefruit juice with simvastatin </content>
<content stylecode="italics">[see <linkhtml href="#i4i_section_id_4fd678af-6eb7-455f-bcb8-e75468f55ff2">Warnings and Precautions (5.1)</linkhtml>]</content>
</td>
</tr>
<tr id="id_b1759a8f-ca8b-49b7-a992-5af216d33b8d">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">
<paragraph>  Grapefruit Juice<footnote id="id-3ab7f3e7-86e0-43e1-a834-16dc6577c95d">The effect of amounts of grapefruit juice between those used in these two studies on simvastatin pharmacokinetics has not been studied.</footnote>
</paragraph>(high dose)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">200 mL of double-strength TID<footnote id="id-597ce83e-b69e-4556-85e5-494e88ee3e33">Double-strength: one can of frozen concentrate diluted with one can of water. Grapefruit juice was administered TID for 2 days, and 200 mL together with single dose simvastatin and 30 and 90 minutes following single dose simvastatin on Day 3.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">60 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid <br/>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">7<br/>16</td>
<td align="center" stylecode="Botrule Rrule" valign="top"></td>
</tr>
<tr id="id_a0532a52-5e74-4366-9597-564501daa14c">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">
<paragraph>  Grapefruit Juice<footnoteref idref="id-3ab7f3e7-86e0-43e1-a834-16dc6577c95d"></footnoteref>
</paragraph>(low dose)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">8 oz (about 237 mL) of single-strength<footnote id="id-93d71354-83aa-422c-9c92-1f60feba4126">Single-strength: one can of frozen concentrate diluted with 3 cans of water. Grapefruit juice was administered with breakfast for 3 days, and simvastatin was administered in the evening on Day 3.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">20 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid <br/>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">1.3<br/>1.9</td>
<td align="center" stylecode="Botrule Rrule" valign="top"></td>
</tr>
<tr id="id_07c6e8d8-95ae-45ce-aa4e-9f14d39a42ad">
<td align="left" colspan="6" stylecode="Botrule Lrule Rrule" valign="top">
<content stylecode="bold">Avoid taking with &gt;10 mg simvastatin</content>, based on clinical and/or postmarketing experience <content stylecode="italics">[see <linkhtml href="#i4i_section_id_4fd678af-6eb7-455f-bcb8-e75468f55ff2">Warnings and Precautions (5.1)</linkhtml>]</content>
</td>
</tr>
<tr id="id_b8919d3e-df8b-4807-8f02-4f976ceb0a02">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Verapamil SR</td>
<td align="center" stylecode="Botrule Rrule" valign="top">240 mg QD Days 1-7 then 240 mg BID on Days 8-10</td>
<td align="center" stylecode="Botrule Rrule" valign="top">80 mg on Day 10</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid <br/>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">2.3<br/>2.5</td>
<td align="center" stylecode="Botrule Rrule" valign="top">2.4<br/>2.1</td>
</tr>
<tr id="id_84eb39ae-4f9d-4868-a417-d095b94dd28b">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Diltiazem</td>
<td align="center" stylecode="Botrule Rrule" valign="top">120 mg BID for 10 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">80 mg on Day 10</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>simvastatin acid </paragraph>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>2.69</paragraph>3.10</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>2.69</paragraph>2.88</td>
</tr>
<tr id="id_807b4717-cd0d-4dbc-ae93-4951208a3762">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Diltiazem</td>
<td align="center" stylecode="Botrule Rrule" valign="top">120 mg BID for 14 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">20 mg on Day 14</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">4.6</td>
<td align="center" stylecode="Botrule Rrule" valign="top">3.6</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Dronedarone</td>
<td align="center" stylecode="Botrule Rrule" valign="top">400 mg BID for 14 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">40 mg QD for 14 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid<br/>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">1.96<br/>3.90</td>
<td align="center" stylecode="Botrule Rrule" valign="top">2.14<br/>3.75</td>
</tr>
<tr id="id_7e4bb008-7250-41e5-8f06-3f15d2559b88">
<td align="left" colspan="6" stylecode="Botrule Lrule Rrule" valign="top">
<content stylecode="bold">Avoid taking with &gt;20 mg simvastatin</content>, based on clinical and/or postmarketing experience <content stylecode="italics">[see <linkhtml href="#i4i_section_id_4fd678af-6eb7-455f-bcb8-e75468f55ff2">Warnings and Precautions (5.1)</linkhtml>]</content>
</td>
</tr>
<tr id="id_09425374-40e3-4971-aaf5-3eca5d6991fc">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Amiodarone</td>
<td align="center" stylecode="Botrule Rrule" valign="top">400 mg QD for 3 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">40 mg on Day 3</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid<br/>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">1.75<br/>1.76</td>
<td align="center" stylecode="Lrule Rrule Botrule" valign="top">1.72<br/>1.79</td>
</tr>
<tr id="id_dc5feef8-cda6-4c24-b3dc-7b4e8068fd03">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Amlodipine</td>
<td align="center" stylecode="Botrule Rrule" valign="top">10 mg QD x 10 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">80 mg on Day 10</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid <br/>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>1.58</paragraph>1.77</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>1.56</paragraph>1.47</td>
</tr>
<tr id="id_807afab2-eaf4-42a3-a55a-720d117e7f9f">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Ranolazine SR</td>
<td align="center" stylecode="Botrule Rrule" valign="top">1000 mg BID for 7 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">80 mg on Day 1 and Days 6-9</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>simvastatin acid </paragraph>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>2.26</paragraph>1.86</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>2.28</paragraph>1.75</td>
</tr>
<tr>
<td align="left" colspan="6" stylecode="Lrule Rrule Botrule" valign="top">
<content stylecode="bold">Avoid taking with &gt;20 mg simvastatin (or 40 mg for patients who have previously taken 80 mg simvastatin chronically, e.g., for 12 months or more, without evidence of muscle toxicity)</content>, based on clinical experience 											</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Lomitapide</td>
<td align="center" stylecode="Botrule Rrule" valign="top">60 mg QD for 7 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">40 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>simvastatin acid </paragraph>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>1.7</paragraph>2</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>1.6</paragraph>2</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Lomitapide</td>
<td align="center" stylecode="Botrule Rrule" valign="top">10 mg QD for 7 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">20 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>simvastatin acid </paragraph>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>1.4</paragraph>1.6</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>1.4</paragraph>1.7</td>
</tr>
<tr id="id_dc0808b6-847c-4d67-b92d-a074f81c27d3">
<td align="left" colspan="6" stylecode="Lrule Rrule Botrule" valign="top">
<content stylecode="bold">No dosing adjustments required for the following:</content>
</td>
</tr>
<tr id="id_b2703f68-9d0c-4ef7-bf65-469ce7af251d">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Fenofibrate</td>
<td align="center" stylecode="Botrule Rrule" valign="top">160 mg QD X 14 days</td>
<td align="center" stylecode="Botrule Rrule" valign="top">80 mg QD on Days 8-14</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid <br/>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">0.64<br/>0.89</td>
<td align="center" stylecode="Botrule Rrule" valign="top">0.89<br/>0.83</td>
</tr>
<tr id="id_6f1bbcdd-a3c3-4e6b-9d6d-c8cbe6bceec1">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Niacin <br/>extended-release<footnote id="id-16e40fa9-5786-4bd0-87e6-ce6566012255">Because Chinese patients have an increased risk for myopathy with simvastatin coadministered with lipid-modifying doses (≥1 gram/day niacin) of niacin-containing products, and the risk is dose-related, Chinese patients should not receive simvastatin 80 mg coadministered with lipid-modifying doses of niacin-containing products <content stylecode="italics">[see <linkhtml href="#i4i_section_id_4fd678af-6eb7-455f-bcb8-e75468f55ff2">Warnings and Precautions (5.1)</linkhtml> and <linkhtml href="#i4i_section_id_da3b6535-c7b9-44cb-8747-588732fb06d0">Drug Interactions (7.4)</linkhtml>]</content>.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">2 g single dose</td>
<td align="center" stylecode="Botrule Rrule" valign="top">20 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">simvastatin acid <br/>simvastatin</td>
<td align="center" stylecode="Botrule Rrule" valign="top">1.6<br/>1.4</td>
<td align="center" stylecode="Botrule Rrule" valign="top">1.84<br/>1.08</td>
</tr>
<tr id="id_68bed7c4-7f6b-4efd-a48d-6567e72cd849">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Propranolol</td>
<td align="center" stylecode="Rrule" valign="top">80 mg single dose</td>
<td align="center" stylecode="Rrule" valign="top">80 mg single dose</td>
<td align="left" stylecode="Rrule" valign="top">
<paragraph>total inhibitor</paragraph>
<br/>active inhibitor</td>
<td align="center" stylecode="Rrule" valign="top">0.79<br/>
<br/>0.79</td>
<td align="center" stylecode="Botrule Rrule" valign="top">↓ from 33.6 to 21.1 ng∙eq/mL<br/>↓ from 7.0 to 4.7 ng∙eq/mL</td>
</tr>
</tbody>
</table><hr><br>Table name: <input type='set_id' size=80' onClick='this.select();' readonly='readonly' value='TABLE-fdbfe194-b845-42c5-bb87-a48118bc72e7-drugInteractions-0.txt'/><table id="id_5fb75b18-994d-4a20-9a3a-419f83595f14" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_55fc3bff-6845-477f-8b07-307a3fc951d0">Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (<linkhtml href="#i4i_section_id_b0581161-99be-44b3-bdec-86cb09743caf">2.3</linkhtml>, <linkhtml href="#i4i_section_id_2047e559-5c8f-4cb4-9ae7-727e8a080bd5">2.4</linkhtml>, <linkhtml href="#i4i_contraindications_id_4075f374-1aea-404c-b31c-2d2ce98df9d2">4</linkhtml>, <linkhtml href="#i4i_section_id_4fd678af-6eb7-455f-bcb8-e75468f55ff2">5.1</linkhtml>, <linkhtml href="#i4i_section_id_7e1615a3-a89a-4732-aa79-e6d67b4c43da">7.1</linkhtml>, <linkhtml href="#i4i_section_id_179d3c13-c346-4247-b12b-046258e855ca">7.2</linkhtml>, <linkhtml href="#i4i_section_id_fd3a2d94-a55a-4da4-a664-c0e6ce6846e3">7.3</linkhtml>, <linkhtml href="#i4i_pharmacokinetics_id_25b1b3f5-7f81-4db6-a229-fc827a32bb83">12.3</linkhtml>)</caption>
<col align="left" valign="top" width="50%"></col>
<col align="left" valign="top" width="50%"></col>
<thead>
<tr id="id_a71da351-3876-418c-a6a3-7144cb2f26de">
<th stylecode="Lrule Rrule">Interacting Agents</th>
<th stylecode="Rrule">Prescribing Recommendations</th>
</tr>
</thead>
<tbody>
<tr id="id_7b3c6ce1-e0e0-457c-b991-57b0fb5de726">
<td align="left" stylecode="Botrule Rrule Lrule" valign="top">Strong CYP3A4 inhibitors (e.g., itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, cobicistat-containing products), gemfibrozil, cyclosporine, danazol</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Contraindicated with simvastatin</td>
</tr>
<tr id="id_10cba7ce-b59a-484a-9832-da2a6a667074">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Verapamil, diltiazem, dronedarone</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Do not exceed 10 mg simvastatin daily</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Amiodarone, amlodipine, ranolazine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Do not exceed 20 mg simvastatin daily</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Lomitapide</td>
<td align="left" stylecode="Botrule Rrule" valign="top">For patients with HoFH, do not exceed 20 mg simvastatin daily<footnote>For patients with HoFH who have been taking 80 mg simvastatin chronically (e.g., for 12 months or more) without evidence of muscle toxicity, do not exceed 40 mg simvastatin when taking lomitapide.</footnote>
</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule" valign="top">Grapefruit juice</td>
<td align="left" stylecode="Rrule" valign="top">Avoid grapefruit juice</td>
</tr>
</tbody>
</table><hr><br></body></html>